Systems, methods, and catheters for endovascular treatment of blood vessels

JP2023552156A5Active Publication Date: 2024-12-06TVA MEDICAL INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023532484
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-30
Filing Date
2021-11-30
Publication Date
2024-12-06
Estimated Expiration
2041-11-30

AI Technical Summary

Technical Problem

Endovascular treatments face challenges in accurately aligning catheters with treatment locations within blood vessels, particularly in complex vasculature, and existing imaging systems like fluoroscopy are expensive, limited in availability, and expose patients and physicians to radiation.

Method used

A system comprising a control unit, ultrasound device, actuator, and catheter with a treatment portion, utilizing echogenic markers and intravascular imaging to enhance catheter positioning and alignment, reducing the need for multiple catheters and minimizing radiation exposure.

Benefits of technology

Improves catheter positioning accuracy and accessibility of treatments by using ultrasound-based systems, reducing the complexity of two-catheter systems and minimizing radiation exposure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Systems, methods, and catheters for endovascular treatment of blood vessels are disclosed. In one aspect, a catheter for endovascular treatment of blood vessels is disclosed. The catheter includes a housing. The catheter further includes a treatment portion. The catheter further includes a fistula forming element. The catheter further includes an intravascular ultrasound imaging device.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims the benefit of co-pending U.S. Provisional Patent Application No. 63 / 119,239, entitled "Systems, Methods, and Catheters for Endovascular Treatment of a Blood Vessel," filed November 30, 2020, which is incorporated herein by reference in its entirety.

[0002]

[0002] This specification relates generally to systems, methods, and catheters for the treatment of blood vessels, and more particularly to systems, methods, and catheters for the endovascular treatment of blood vessels. Summary of the Invention [Problem to be solved by the invention]

[0003]

[0003] Endovascular treatments treat various vascular disorders from within blood vessels using long, thin tubes called catheters that are placed within blood vessels to deliver treatment. Endovascular treatments include, but are not limited to, intravascular arteriovenous fistula (endoAVF) creation, arteriovenous (AV) treatment, and peripheral arterial disease (PAD) treatment. One of the most challenging aspects of endovascular treatment is properly aligning the treatment portion of the catheter with the correct treatment location on the blood vessel. In addition, treatments such as intravascular fistula creation may require positioning two catheters in adjacent blood vessels to create a fistula between them. However, aligning and placing two separate catheters can also be difficult and cumbersome for physicians.

[0004]

[0004] Additionally, imaging systems for visualizing the positioning of catheters within blood vessels can also present numerous obstacles to overcome. Fluoroscopy equipment, in particular, can be very expensive and therefore may not be available outside of operating rooms or in rural areas. Furthermore, repeated use of fluoroscopy equipment can expose not only the patient but also the physician to radiation. Such repeated exposure can eventually affect the physician's health. Additionally, the contrast agents used in fluoroscopy may not be suitable for patients with certain conditions (e.g., chronic kidney disease).

[0005]

[0005] Therefore, there is a need for alternative systems, methods, and catheters for endovascular treatment of blood vessels that improve catheter alignment techniques within the blood vessel, and / or catheters for endovascular treatment of blood vessels that allow for easier delivery of treatment to the blood vessel.

[0006] The present embodiments address the above-mentioned problems. In particular, the present disclosure is directed to systems, methods, and catheters for improved visualization and alignment techniques for delivering treatment (e.g., fistula formation) to blood vessels using one or more catheters. Additionally, some embodiments are directed to a single-catheter system that can reduce the complexity of current two-catheter systems.

[0007] In a first aspect, a system for endovascular treatment of a blood vessel includes a control unit, an ultrasound device, an actuator, and a catheter having a treatment portion. The ultrasound device is communicatively coupled to the control unit. The ultrasound device includes an ultrasound probe having a subject-contacting surface. The actuator is coupled to the ultrasound probe and is operable to move the subject-contacting surface of the ultrasound probe relative to a treatment area of ​​the subject. The control unit is configured to determine a position of the treatment portion of the catheter as the catheter is advanced through the blood vessel, and to cause the actuator to move the subject-contacting surface of the ultrasound probe relative to the treatment area of ​​the subject to track the position of the catheter as the catheter is advanced through the blood vessel.

[0008]

[0008] In a second aspect, the present disclosure includes a system according to the first aspect, wherein the system further includes one or more user input devices communicatively coupled to the control unit, and the control unit is further configured to receive user input from the one or more user input devices and switch from an automatic follow mode to a manual operating mode to enable manual control of movement of the ultrasound probe based on input from the one or more user input devices.

[0009]

[0009] In a third aspect, the present disclosure includes a system according to any of the preceding aspects, wherein the system further includes a display communicatively coupled to the control unit, the control unit further configured to display one or more ultrasound images on the display in real time as the catheter advances through the blood vessel.

[0010]

[0010] In a fourth aspect, the present disclosure includes a system according to the third aspect, wherein the control unit is further configured to determine an orientation of the treatment portion of the catheter within the blood vessel and output an indication of the orientation of the treatment portion of the catheter via a display.

[0011]

[0011] In a fifth aspect, the present disclosure includes a system according to any of the preceding aspects, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and a sagittal plane ultrasound image.

[0012]

[0012] In a sixth aspect, the present disclosure includes a system according to any of the preceding aspects, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to recognize one or more vessels in an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on the display.

[0013]

[0013] In a seventh aspect, the present disclosure includes a system according to any of the preceding aspects, wherein the system further includes a media reservoir configured to be placed over a treatment area of ​​a subject, the ultrasound device moving within the media reservoir.

[0014]

[0014] In an eighth aspect, the present disclosure includes a system according to the seventh aspect, wherein the media reservoir comprises a flexible subject interface, the flexible subject interface conforming to the shape of the treatment area of ​​the subject.

[0015]

[0015] In a ninth aspect, the present disclosure includes a system according to the seventh or eighth aspect, wherein the media vessel comprises a housing with a track, and the ultrasonic device is movable along the track.

[0016]

[0016] In a tenth aspect, the present disclosure includes a system according to any of the preceding aspects, wherein the catheter comprises a housing, a cutting device, and a biasing mechanism, the biasing mechanism being coupled to the catheter housing and configured to bias the cutting device against the wall of the blood vessel.

[0017] In an eleventh aspect, the present disclosure includes a system according to the tenth aspect, wherein the biasing mechanism is a balloon.

[0018] In a twelfth aspect, the present disclosure includes a system according to the tenth aspect, wherein the biasing mechanism is an expandable cage.

[0018]

[0019] In a thirteenth aspect, the present disclosure includes a system according to any of the tenth to twelfth aspects, wherein the biasing mechanism comprises one or more expandable wires movable between a collapsed position and an extended position, at least a portion of the one or more expandable wires being positioned spaced apart from an outer wall of the catheter housing.

[0019]

[0020] In a fourteenth aspect, the present disclosure includes a system according to any of the tenth to thirteenth aspects, wherein the catheter comprises one or more echogenic markers, the one or more echogenic markers indicating rotational alignment of a cutting device of the catheter.

[0020]

[0021] In a fifteenth aspect, a system for endovascular treatment of a blood vessel includes a control unit, an imaging device, a display, and a catheter having a treatment portion. The imaging device and the display are communicatively coupled to the control unit. The control unit is configured to display an image of the blood vessel, determine a rotational orientation of the treatment portion of the catheter within the blood vessel, and output an indication of the rotational orientation of the treatment portion of the catheter via the display.

[0021]

[0022] In a sixteenth aspect, the present disclosure includes a system according to the fifteenth aspect, wherein the instructions include an overlay projected onto the image of the blood vessel, the overlay providing an indication of the rotational orientation of the treatment portion of the catheter.

[0022]

[0023] In a seventeenth aspect, the present disclosure includes a system according to the fifteenth or sixteenth aspect, wherein the imaging device is an ultrasound imaging device.

[0024] In an eighteenth aspect, the present disclosure includes a system according to any of the fifteenth to seventeenth aspects, wherein the imaging device is an intravascular imaging device.

[0023]

[0025] In a nineteenth aspect, the present disclosure includes a system according to any of the fifteenth to eighteenth aspects, wherein the imaging device is coupled to the catheter at a location distal to the treatment portion.

[0024]

[0026] In a twentieth aspect, the present disclosure includes a system according to any of the fifteenth to nineteenth aspects, wherein the imaging device is coupled to the catheter at a location proximal to the treatment portion.

[0025]

[0027] In a twenty-first aspect, the present disclosure includes a system according to any of the fifteenth to twentieth aspects, wherein the imaging device is a 3D ultrasound device, and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and a sagittal plane ultrasound image via the display.

[0026]

[0028] In a twenty-second aspect, the present disclosure includes a system according to any of the fifteenth to twenty-first aspects, wherein the ultrasound device is a 3D ultrasound device, and the control unit is configured to recognize one or more vessels in an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on the display.

[0027]

[0029] In a 23rd aspect, the present disclosure includes a system according to any of the 15th to 22nd aspects, wherein the catheter comprises a housing, and the treatment portion of the catheter is coupled to the housing of the catheter at a first radial position.

[0028]

[0030] In a twenty-fourth aspect, the present disclosure includes a system according to the twenty-third aspect, wherein the catheter further comprises a biasing mechanism coupled to the housing of the catheter, the biasing mechanism configured to bias the treatment portion of the catheter toward the wall of the blood vessel.

[0029]

[0031] In a twenty-fifth aspect, the present disclosure includes a system according to the twenty-fourth aspect, wherein the biasing mechanism is coupled to a housing of the catheter proximate the treatment portion.

[0032] In a twenty-sixth aspect, the present disclosure includes a system according to any of the fifteenth to twenty-fifth aspects, wherein the treatment portion comprises a cutting device.

[0030]

[0033] In a twenty-seventh aspect, the present disclosure includes a system according to any of the twenty-fourth to twenty-sixth aspects when dependent on the twenty-fourth aspect, wherein the biasing mechanism is a balloon.

[0034] In a twenty-ninth aspect, the present disclosure includes a system according to any of the twenty-fourth to twenty-sixth aspects when dependent on the twenty-fourth aspect, wherein the biasing mechanism comprises one or more expandable wires movable between a collapsed position and an extended position, at least a portion of the one or more expandable wires being positioned spaced apart from an outer wall of the catheter housing.

[0031]

[0035] In a thirtieth aspect, the present disclosure includes a system according to any of the fifteenth to twenty-ninth aspects, wherein the catheter comprises one or more echogenic markers, the one or more echogenic markers indicating rotational alignment of a cutting device of the catheter.

[0032]

[0036] In a thirty-first aspect, the present disclosure includes a catheter for intravascular treatment of a blood vessel, the catheter including a housing, a treatment portion coupled to the housing, an intravascular imaging device coupled to the housing, and a biasing mechanism coupled to the housing, the biasing mechanism configured to contact a wall of the blood vessel and bias the treatment portion into contact with the wall of the blood vessel.

[0033]

[0037] In a thirty-second aspect, the present disclosure includes a system according to the thirty-first aspect, wherein the biasing mechanism is configured to contact a first radial portion of the wall of the blood vessel and bias the treatment portion toward a second radial portion of the wall of the blood vessel opposite the first radial portion.

[0034]

[0038] In a thirty-third aspect, the present disclosure includes a system according to the thirty-first aspect or the thirty-second aspect, wherein the intravascular imaging device is coupled to the housing of the catheter at a location distal to the treatment portion.

[0035]

[0039] In a thirty-fourth aspect, the present disclosure includes a system according to the thirty-first aspect or the thirty-second aspect, wherein the intravascular imaging device is coupled to the housing of the catheter at a location proximal to the treatment portion.

[0036]

[0040] In a thirty-fifth aspect, the present disclosure includes a system according to the thirty-first aspect or the thirty-second aspect, wherein the intravascular imaging device is coupled to the housing of the catheter in a position longitudinally aligned with the treatment portion of the catheter.

[0037]

[0041] In a thirty-sixth aspect, the present disclosure includes a system according to any of the thirty-first to thirty-fifth aspects, wherein the treatment portion comprises an electrode including an arc extending from the housing, and the intravascular imaging device is positioned to capture image data of a cross section of the catheter taken perpendicular to the longitudinal direction of the catheter at the apex of the arc.

[0038]

[0042] In a thirty-seventh aspect, the present disclosure includes a system according to any of the thirty-first to thirty-sixth aspects, wherein the intravascular imaging device is positioned longitudinally within the treatment portion of the catheter.

[0039]

[0043] In a thirty-eighth aspect, the present disclosure includes a system according to any of the thirty-first to thirty-seventh aspects, wherein the treatment portion comprises an electrode, and an intravascular imaging device is positioned longitudinally relative to the treatment portion of the catheter so as to capture image data of a cross section of the electrode.

[0040]

[0044] In a thirty-ninth aspect, the present disclosure includes a system according to any of the thirty-first to thirty-eighth aspects, wherein the biasing mechanism is coupled to a housing of the catheter proximate the treatment portion.

[0041]

[0045] In a fortieth aspect, the present disclosure includes a system according to any of the thirty-first to thirty-ninth aspects, wherein the treatment portion comprises a cutting device.

[0046] In a forty-first aspect, the present disclosure includes a system according to any of the thirty-first to fortieth aspects, wherein the biasing mechanism is a balloon.

[0042]

[0047] In a forty-second aspect, the present disclosure includes a system according to any of the thirty-first to fortieth aspects, wherein the biasing mechanism is an expandable cage.

[0048] In a forty-third aspect, a method for endovascular treatment of a blood vessel includes advancing a catheter within the blood vessel to a treatment location on the blood vessel, aligning a treatment portion of the catheter with the treatment location on the blood vessel, and deploying the catheter with a biasing mechanism coupled to a body of the catheter, the biasing mechanism configured to contact a first radial portion of the blood vessel and bias the treatment portion of the catheter toward the treatment location on the blood vessel opposite the first radial portion.

[0043]

[0049] In a forty-fourth aspect, the present disclosure includes a method according to the forty-third aspect, wherein the treatment portion comprises a cutting device.

[0050] In a forty-fifth aspect, the present disclosure includes a method according to the forty-third or forty-fourth aspect, wherein the biasing mechanism is a balloon.

[0044]

[0051] In a forty-sixth aspect, the present disclosure includes a method according to the forty-third or forty-fourth aspect, wherein the biasing mechanism is an expandable cage.

[0052] In a forty-seventh aspect, the present disclosure includes a method according to any of the forty-third to forty-sixth aspects, wherein the biasing mechanism is coupled to a housing of the catheter proximate the treatment portion.

[0045]

[0053] In a 48th aspect, the present disclosure includes a method according to any of the 43rd to 47th aspects, further including the steps of determining the position of the treatment portion of the catheter by a control unit as the catheter advances through the blood vessel, moving the imaging device by an actuator to follow the position of the catheter as the catheter advances through the blood vessel, and displaying one or more images from the imaging device in real time by a display as the catheter advances through the blood vessel.

[0046]

[0054] In a forty-ninth aspect, the present disclosure includes a method according to any of the forty-third to forty-eighth aspects, the method further including the steps of capturing image data by an imaging device coupled to the catheter, and displaying the image data from the imaging device in real time by a display as the catheter advances through the blood vessel.

[0047]

[0055] In a 50th aspect, the present disclosure includes a method according to any of the 43rd to 49th aspects, the method further including the steps of determining the rotational alignment of the catheter and displaying an indication of the rotational alignment of the catheter by a display.

[0048]

[0056] In a 51st aspect, the present disclosure includes a method according to any of the 43rd to 50th aspects, the method further including a step of determining the rotational alignment of the treatment portion of the catheter and a step of displaying an indication of the rotational alignment of the treatment portion of the catheter by a display.

[0049]

[0057] In a 52nd aspect, the present disclosure includes a method according to any of the 43rd to 51st aspects, further comprising automatically adjusting the imaging device to automatically focus the imaging device on the treatment portion of the catheter and adjusting image quality using one or more position sensors and / or echogenic markers.

[0050]

[0058] In a 53rd aspect, the present disclosure includes a system according to any of the 15th to 30th aspects, wherein the imaging device is an ultrasound device, and the control unit is configured to recognize arterial blood flow using a Doppler function of the ultrasound device, recognize venous blood flow using the Doppler function of the ultrasound device, and display a vascular map based on the arterial blood flow and venous blood flow.

[0051]

[0059] In a fifty-fourth aspect, the present disclosure includes a system according to the fifty-third aspect, wherein in the vascular map, arterial blood flow is depicted in a first color and venous blood flow is depicted in a second color different from the first color.

[0052]

[0060] In a 55th aspect, the present disclosure includes a system according to the 53rd or 54th aspects, wherein the control unit is configured to recognize fistula creation by identifying blood flow between adjacent arteries and veins using the Doppler function of the ultrasound device.

[0053]

[0061] In a fifty-sixth aspect, the present disclosure includes a control unit for endovascular treatment of a blood vessel with one or more catheters. The control unit includes one or more processors and one or more memory modules communicatively coupled to the one or more processors. The control unit is configured to be communicatively coupled to an imaging device and a display. When the one or more processors execute logic stored in the one or more memory modules, the control unit displays image data of the blood vessel from the imaging device, determines a rotational orientation of a treatment portion of the catheter within the blood vessel, and outputs an indication of the rotational orientation of the treatment portion of the catheter via the display.

[0054]

[0062] In a 57th aspect, the present disclosure includes a control unit according to the 56th aspect, wherein the instructions include an overlay projected onto the image of the blood vessel, the overlay providing an indication of the rotational orientation of the treatment portion of the catheter.

[0055]

[0063] In a fifty-eighth aspect, the present disclosure includes a control unit according to the fifty-sixth aspect or the fifty-seventh aspect, wherein the imaging device is an ultrasound imaging device.

[0064] In a fifty-ninth aspect, the present disclosure includes a control unit according to any of the fifty-sixth to fifty-eighth aspects, wherein the imaging device is an intravascular imaging device.

[0056]

[0065] In a sixtieth aspect, the present disclosure includes a control unit according to any of the fifty-sixth to fifty-ninth aspects, wherein the imaging device is coupled to the catheter at a location distal to the treatment portion.

[0057]

[0066] In a sixty-first aspect, the present disclosure includes a control unit according to any of the fifty-sixth to fifty-ninth aspects, wherein the imaging device is coupled to the catheter at a position proximal to the treatment portion.

[0058]

[0067] In a 62nd aspect, the present disclosure includes a control unit according to any of the 56th to 61st aspects, wherein the imaging device is a 3D ultrasound device, and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and a sagittal plane ultrasound image via a display.

[0059]

[0068] In a 63rd aspect, the present disclosure includes a control unit according to any of the 56th to 62nd aspects, wherein the ultrasound device is a 3D ultrasound device, and the control unit is configured to recognize one or more vessels in an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on a display.

[0060]

[0069] In a 64th aspect, the present disclosure includes a control unit according to any of the 56th to 63rd aspects, wherein the control unit is configured to be communicatively coupled to one or more position sensors coupled to the catheter, the one or more position sensors output position signals indicative of the position of the treatment portion, and the control unit is configured to determine the position of the treatment portion based on signals from the one or more position sensors.

[0061]

[0070] In a 65th aspect, the present disclosure includes a control unit according to any of the 56th to 64th aspects, wherein the imaging device is an ultrasound device, and the control unit is configured to recognize arterial blood flow using the Doppler function of the ultrasound device, recognize venous blood flow using the Doppler function of the ultrasound device, and display a vascular map based on the arterial blood flow and venous blood flow.

[0062]

[0071] In a 66th aspect, the present disclosure includes a control unit according to the 65th aspect, wherein in the vascular map, arterial blood flow is depicted in a first color and venous blood flow is depicted in a second color different from the first color.

[0063]

[0072] In a 67th aspect, the present disclosure includes a control unit according to any of the 56th to 66th aspects, wherein the control unit is configured to recognize fistula creation by identifying blood flow between adjacent arteries and veins using the Doppler function of the ultrasound device.

[0064]

[0073] In a sixty-eighth aspect, the present disclosure includes a control unit for endovascular treatment of a blood vessel using one or more catheters. The control unit includes one or more processors and one or more memory modules communicatively coupled to the one or more processors. The control unit is configured to be communicatively coupled to an ultrasound probe having a subject-contacting surface and an actuator coupled to the ultrasound probe. When the one or more processors execute logic stored by the one or more memory modules, the control unit determines a position of a treatment portion of the catheter as the catheter advances through the blood vessel and causes the actuator to move the subject-contacting surface of the ultrasound probe relative to a treatment area of ​​the subject to track the position of the catheter as the catheter advances through the blood vessel.

[0065]

[0074] In a sixty-ninth aspect, the present disclosure includes a control unit according to the sixty-eighth aspect, wherein the control unit is configured to be communicatively coupled to one or more user input devices, and the control unit is further configured to receive user input from the one or more user input devices and switch from an automatic tracking mode to a manual operating mode to enable manual control of movement of the ultrasound probe based on input from the one or more user input devices.

[0066]

[0075] In a 70th aspect, the present disclosure includes a control unit according to the 68th aspect or the 69th aspect, wherein the control unit is configured to be communicatively coupled to a display, and the control unit is further configured to display one or more ultrasound images by the display in real time as the catheter advances through the blood vessel.

[0067]

[0076] In a 71st aspect, the present disclosure includes a control unit according to any of the 68th to 70th aspects, wherein the control unit is further configured to determine an orientation of a treatment portion of the catheter within a blood vessel and output an indication of the orientation of the treatment portion of the catheter via a display.

[0068]

[0077] In a 72nd aspect, the present disclosure includes a control unit according to any of the 68th to 71st aspects, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and a sagittal plane ultrasound image.

[0069]

[0078] In a 73rd aspect, the present disclosure includes a control unit according to any of the 68th to 72nd aspects, wherein the ultrasound device is a 3D ultrasound device, and the control unit is configured to recognize one or more vessels in an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on the display.

[0070]

[0079] In a 74th aspect, the present disclosure includes a control unit according to any of the 68th to 73rd aspects, wherein the catheter comprises one or more echogenic markers, and the control unit is configured to determine a rotational orientation of the catheter based on recognition of the one or more echogenic markers.

[0071]

[0080] In a 75th aspect, the present disclosure includes a control unit according to any of the 68th to 74th aspects, wherein the control unit is configured to be communicatively coupled to one or more position sensors coupled to the catheter, the one or more position sensors output position signals indicative of the position of the treatment portion, and the control unit is configured to determine the position of the treatment portion based on signals from the one or more position sensors.

[0072]

[0081] In a seventy-sixth aspect, the present disclosure includes a catheter for intravascular treatment of a blood vessel, the catheter comprising a housing, a treatment portion, a fistula forming element, and an intravascular ultrasound imaging device.

[0073]

[0082] In a seventy-seventh aspect, the present disclosure includes a catheter according to the seventy-sixth aspect, wherein the intravascular ultrasound imaging device further comprises a solid-state transducer array.

[0083] In a seventy-eighth aspect, the present disclosure includes a catheter according to any of the seventy-sixth to seventy-seventh aspects, wherein the solid-state transducer array is positioned distal to the fistula forming element.

[0074]

[0084] In a seventy-ninth aspect, the present disclosure includes a catheter according to any of the seventy-sixth to seventy-eighth aspects, wherein the solid-state transducer array is positioned proximal to the fistula forming element.

[0085] In an eightieth aspect, the present disclosure includes a catheter according to any of the seventy-sixth to seventy-ninth aspects, wherein the solid-state transducer array is coupled to a housing of the catheter.

[0075]

[0086] In an eighty-first aspect, the present disclosure includes a catheter according to any of the seventy-sixth to eightyth aspects, wherein the solid-state transducer array is circumferentially disposed around the housing of the catheter.

[0076]

[0087] In an 82nd aspect, the present disclosure includes a catheter according to any of the 76th to 81st aspects, wherein the intravascular ultrasound imaging device further comprises one or more flexible circuit elements electrically coupled to the solid-state transducer array.

[0077]

[0088] In an 83rd aspect, the present disclosure includes a catheter according to any of the 76th to 82nd aspects, wherein the one or more flexible circuit elements further comprise one or more multiplexed application-specific integrated circuits.

[0078]

[0089] In an 84th aspect, the present disclosure includes a catheter according to any of the 76th to 83rd aspects, wherein the one or more flexible circuit elements are disposed within a housing of the catheter.

[0079]

[0090] In an 85th aspect, the present disclosure includes a catheter according to any of the 76th to 84th aspects, wherein the catheter further comprises an intravascular ultrasound imaging device wire extending proximally from the one or more flexible circuit elements through the housing of the catheter.

[0080]

[0091] In an 86th aspect, the present disclosure includes a catheter according to any of aspects 76 to 85, wherein one or more flexible circuit elements are positioned distal to the fistula forming element and proximal to the solid-state transducer array.

[0081]

[0092] In an 87th aspect, the present disclosure includes a catheter according to any of aspects 76 to 86, wherein one or more flexible circuit elements are positioned proximal to the solid-state transducer array, and the solid-state transducer array is positioned proximal to the fistula forming element.

[0082]

[0093] In an 88th aspect, the present disclosure includes a catheter according to any of the 76th to 87th aspects, wherein the fistula forming element is an electrode configured to cauterize tissue.

[0094] In an 89th aspect, the present disclosure includes a catheter according to any of the 76th to 88th aspects, wherein the electrode housing is positioned along a treatment portion of the catheter, and the electrode housing is at least partially disposed within the housing of the catheter.

[0083]

[0095] In a 90th aspect, the present disclosure includes a catheter according to any of the 76th to 89th aspects, wherein the electrode is contained within the electrode housing when the electrode is in the low-profile configuration.

[0084]

[0096] In a 91st aspect, the present disclosure includes a catheter according to any of the 76th to 90th aspects, wherein the electrodes are configured to extend radially from the electrode housing and the catheter housing when the electrodes are in the extended configuration.

[0085]

[0097] In a 92nd aspect, the present disclosure includes a catheter according to any of the 76th to 91st aspects, wherein the electrode is spring-biased from a low-profile configuration in which the electrode is contained within the electrode housing to an extended configuration in which the electrode extends radially from the electrode housing and the catheter housing.

[0086]

[0098] In a 93rd aspect, the present disclosure includes a catheter according to any of the 76th to 92nd aspects, wherein the intravascular ultrasound imaging device further comprises a solid-state transducer array, one or more flexible circuit elements electrically coupled to the solid-state transducer array, and an intravascular ultrasound imaging device wire extending proximally from the one or more flexible circuit elements through a housing of the catheter.

[0087]

[0099] In a 94th aspect, the present disclosure includes a catheter according to any of aspects 76 to 93, wherein the electrode housing further comprises a channel extending through the electrode housing, the solid-state transducer array is disposed distal to the electrode housing, one or more flexible circuit elements are disposed distal to the electrode housing, and an intravascular ultrasound imaging device wire extends through the channel extending through the electrode housing.

[0088]

[0100] In a 95th aspect, the present disclosure includes a catheter according to any of the 76th to 94th aspects, wherein the catheter further comprises a first lumen extending through a housing of the catheter and a second lumen extending through the housing of the catheter, the electrode further comprises an electrode wire electrically coupled to the electrode, the electrode wire extending proximally from the electrode through the housing of the catheter within the first lumen, and an intravascular ultrasound imaging device wire extending through the second lumen.

[0089]

[0101] In a 96th aspect, the present disclosure includes a catheter according to any of the 76th to 95th aspects, wherein the first lumen further comprises an insulating sleeve.

[0102] In a 97th aspect, the present disclosure includes a catheter according to any of the 76th to 96th aspects, wherein the catheter further comprises a biasing mechanism coupled to the housing, the biasing mechanism configured to contact a wall of the blood vessel and bias the treatment portion into contact with the wall of the blood vessel.

[0090]

[0103] In a 98th aspect, the present disclosure includes a catheter according to any of the 76th to 97th aspects, wherein the biasing mechanism is configured to contact a first radial portion of the wall of the blood vessel and bias the treatment portion toward a second radial portion of the wall of the blood vessel opposite the first radial portion.

[0091]

[0104] In a 99th aspect, the present disclosure includes a catheter according to any of the 76th to 98th aspects, wherein the biasing mechanism is a balloon.

[0105] In a 100th aspect, the present disclosure includes a catheter according to any of the 76th to 99th aspects, wherein the biasing mechanism is an expandable cage.

[0092]

[0106] In a 101st aspect, the present disclosure includes a catheter according to any of the 76th to 100th aspects, wherein the biasing mechanism comprises one or more expandable wires movable between a collapsed position and an extended position, at least a portion of the one or more expandable wires being positioned spaced apart from an outer wall of the catheter housing.

[0093]

[0107] In a 102nd aspect, the present disclosure includes a catheter according to any of the 76th to 101st aspects, wherein the housing further comprises a rapid exchange tip at a distal end of the catheter.

[0094]

[0108] In a 103rd aspect, the present disclosure includes a catheter according to any of the 76th to 102nd aspects, wherein the housing is constructed from one or more polymers.

[0109] In a 104th aspect, the present disclosure includes a catheter according to any of the 76th to 103rd aspects, wherein the housing is constructed from silicone rubber, nylon, polyurethane, polyethylene terephthalate, latex, or a thermoplastic elastomer.

[0095]

[0110] In a 105th aspect, the present disclosure includes a catheter according to any of the 76th to 104th aspects, wherein the housing is further constructed from a braided polymer.

[0111] In a 106th aspect, the present disclosure includes a method for forming a fistula in a blood vessel, the method including the steps of advancing a catheter within the blood vessel to a treatment location on the blood vessel; generating an image of the blood vessel from data collected from an intravascular ultrasound imaging device of the catheter; aligning a treatment portion of the catheter with the treatment location on the blood vessel; deploying the catheter with a biasing mechanism coupled to a housing of the catheter, the biasing mechanism configured to contact a first radial portion of the blood vessel and bias the treatment portion of the catheter toward the treatment location on the blood vessel opposite the first radial portion; deploying electrodes from the treatment portion; and ablatating the blood vessel at the treatment location.

[0096]

[0112] In a 107th aspect, the present disclosure includes a method according to the 106th aspect, wherein the intravascular ultrasound imaging device further comprises a solid-state transducer array, one or more flexible circuit elements electrically coupled to the solid-state transducer array and disposed within the housing of the catheter, and an intravascular ultrasound imaging device wire extending proximally from the one or more flexible circuit elements through the housing of the catheter.

[0097]

[0113] In a 108th aspect, the present disclosure includes a method according to any of the 106th to 107th aspects, wherein the solid state transducer array is circumferentially disposed around the housing of the catheter.

[0098]

[0114] In a 109th aspect, the present disclosure includes a method according to any of the 106th to 108th aspects, wherein the biasing mechanism is a balloon.

[0115] In a 110th aspect, the present disclosure includes a method according to any of the 106th to 109th aspects, wherein the biasing mechanism is an expandable cage.

[0099]

[0116] In a 111th aspect, the present disclosure includes a method according to any of aspects 106 to 110, wherein the biasing mechanism comprises one or more expandable wires movable between a collapsed position and an extended position, at least a portion of the one or more expandable wires being positioned spaced apart from an outer wall of the catheter housing.

[0100]

[0117] In a 112th aspect, the present disclosure includes a system for forming a fistula between two blood vessels, the system comprising a first catheter having a first catheter body, an electrode, and a biasing stent, the electrode configured to protrude from a treatment portion of the first catheter and define an active side of the first catheter, the biasing stent configured to extend longitudinally along a length of the first catheter body and extend radially away from the first catheter body between a proximal point and a distal point, the biasing stent extending from the inactive side of the first catheter body, whereby the biasing stent is configured to bias the treatment portion against a wall of the first blood vessel, and the system further comprises a second catheter.

[0101]

[0118] In a 113th aspect, the present disclosure includes a system according to the 112th aspect, wherein the actuated stent includes a first tapered section, a second tapered section, and a third section longitudinally disposed between the first tapered section and the second tapered section.

[0102]

[0119] In a 114th aspect, the present disclosure includes the system of any of aspects 112 to 113, wherein the first tapered section is coupled to the first catheter body at a proximal point of the first tapered section, the first tapered section connects to the third section of the biased stent at a distal point of the first tapered section, and the second tapered section is coupled to the first catheter body at a distal point of the second tapered section, and the second tapered section connects to the third section of the biased stent at a proximal point of the second tapered section.

[0103]

[0120] In a 115th aspect, the present disclosure includes the system of any of aspects 112 to 114, wherein when the biased stent is in an extended configuration, a distal point of the first tapered section is located at a greater distance from the first catheter body than a proximal point of the first tapered section, and a proximal point of the second tapered section is located at a greater distance from the first catheter body than a distal point of the second tapered section.

[0104]

[0121] In a 116th aspect, the present disclosure includes the system of any of aspects 112 to 115, wherein when the biased stent is in an extended configuration, the first tapered section slopes from the first catheter body to the third section of the biased stent, and the second tapered section slopes from the first catheter body to the third section of the biased stent.

[0105]

[0122] In a 117th aspect, the present disclosure includes the system of any of the 112th to 116th aspects, wherein the biased stent includes an elliptical cross-section.

[0123] In a 118th aspect, the present disclosure includes the system of any of the 112th to 117th aspects, wherein the biased stent includes a semi-elliptical cross-section.

[0106]

[0124] In a 119th aspect, the present disclosure includes the system of any of aspects 112 to 118, wherein the first catheter further comprises a sheath configured to be advanced distally to compress the actuated stent against the first catheter body.

[0107]

[0125] In a 120th aspect, the present disclosure includes the system of any of the 112th to 119th aspects, wherein the biased stent comprises nitinol, stainless steel, polyetheretherketone, polyethyleneterephthalate, polyimide, or polytetrafluoroethylene.

[0108]

[0126] In a 121st aspect, the present disclosure includes a system of any of aspects 112 to 120, wherein the actuated stent comprises a plurality of interconnected struts, and the plurality of interconnected struts comprise a substantially flat ribbon having a substantially rectangular cross-section.

[0109]

[0127] In a 122nd aspect, the present disclosure includes a system of any of aspects 112 to 121, wherein the actuated stent comprises a plurality of interconnected struts, and the plurality of interconnected struts comprises a circular cross-section.

[0110]

[0128] In a 123rd aspect, the present disclosure includes the system of any of aspects 112 to 122, wherein the treatment portion is longitudinally positioned between a proximal point and a distal point.

[0129] In a 124th aspect, the present disclosure includes the system of any of aspects 112 to 123, wherein the distal point is positioned on the inactive side of the treatment portion.

[0111]

[0130] In a 125th aspect, the present disclosure includes the system of any of the 112th to 124th aspects, wherein the distal point is located proximal to the distal tip of the first catheter body.

[0131] In a 126th aspect, the present disclosure includes the system of any of aspects 112 to 125, wherein the actuated stent is firmly bonded at distal and proximal points to the first catheter body by an adhesive or polymer.

[0112]

[0132] In a 127th aspect, the present disclosure includes the system of any of aspects 112 to 126, wherein at least one of the proximal point or the distal point at least partially defines a track within the first catheter body, and at least a portion of the biased stent is configured to slide within the track of the first catheter body between an extended position and a low-profile position.

[0113]

[0133] In a 128th aspect, the present disclosure includes the system of any of aspects 112 to 127, wherein the first catheter comprises one or more magnet arrays arranged longitudinally along the first catheter body.

[0114]

[0134] In a 129th aspect, the present disclosure includes the system of any of aspects 112 to 128, wherein the proximal point is positioned proximal to a first end of at least one of the one or more magnetic arrays and the distal point is positioned distal to a second end of at least one of the one or more magnetic arrays, whereby the actuated stent longitudinally spans at least one of the one or more magnetic arrays.

[0115]

[0135] In a 130th aspect, the present disclosure includes a system of any of aspects 112 to 129, wherein at least one of the proximal point or the distal point is longitudinally disposed between a first end of at least one of the one or more magnetic arrays and a second end of at least one of the one or more magnetic arrays.

[0116]

[0136] In a 131st aspect, the present disclosure includes a system of any of aspects 112 to 130, wherein the first catheter is configured to be placed in a first blood vessel and the second catheter is configured to be placed in a second blood vessel adjacent to the first blood vessel.

[0117]

[0137] In a 132nd aspect, the present disclosure includes the system of any of aspects 112 to 131, wherein the second catheter further comprises a concave region defining an active side of the second catheter, the concave region configured to receive an electrode of the first catheter.

[0118]

[0138] In a 133rd aspect, the present disclosure includes the system of any of aspects 112 to 132, wherein the second catheter further comprises a second catheter body and a second biasing stent, the second biasing stent configured to extend longitudinally along the length of the second catheter body and extend radially away from the second catheter body between a proximal point and a distal point, the second biasing stent extending from the inactive side of the second catheter body, whereby the second biasing stent is configured to bias the concave region against the second vessel wall.

[0119]

[0139] In a 134th aspect, the present disclosure includes the system of any of the 112th to 133rd aspects, wherein the concave region is disposed longitudinally between the proximal point and the distal point.

[0140] In a 135th aspect, the present disclosure includes the system of any of aspects 112 to 134, wherein the second catheter further comprises one or more magnet arrays arranged longitudinally along the second catheter body.

[0120]

[0141] In a 136th aspect, the present disclosure includes a catheter comprising a catheter body, an electrode, and a biasing stent, the electrode configured to protrude from a treatment portion of the catheter and define an active side of the catheter, the biasing stent configured to extend longitudinally along the length of the catheter body and extend radially away from the catheter body between a proximal point and a distal point, the biasing stent extending from the inactive side of the catheter body, whereby the biasing stent is configured to bias the treatment portion against a first vessel wall.

[0121]

[0142] In a 137th aspect, the present disclosure includes a catheter according to the 136th aspect, wherein the actuated stent comprises a first tapered section, a second tapered section, and a third section longitudinally disposed between the first tapered section and the second tapered section.

[0122]

[0143] In a 138th aspect, the present disclosure includes a catheter of any of aspects 136 to 137, wherein the first tapered section is coupled to the catheter body at a proximal point of the first tapered section, the first tapered section connects to a third section of the biased stent at a distal point of the first tapered section, and the second tapered section is coupled to the catheter body at a distal point of the second tapered section, and the second tapered section connects to the third section of the biased stent at a proximal point of the second tapered section.

[0123]

[0144] In a 139th aspect, the present disclosure includes a catheter of any of aspects 136 to 138, wherein when the biased stent is in an extended configuration, a distal point of the first tapered section is located at a greater distance from the catheter body than a proximal point of the first tapered section, and a proximal point of the second tapered section is located at a greater distance from the catheter body than a distal point of the second tapered section.

[0124]

[0145] In a 140th aspect, the present disclosure includes a catheter of any of aspects 136 to 139, wherein when the biased stent is in an extended configuration, the first tapered section slopes from the catheter body to the third section of the biased stent, and the second tapered section slopes from the catheter body to the third section of the biased stent.

[0125]

[0146] In a 141st aspect, the present disclosure includes the catheter of any of the 136th to 140th aspects, wherein the biased stent includes an elliptical cross-section.

[0147] In a 142nd aspect, the present disclosure includes the catheter of any of the 136th to 141st aspects, wherein the biased stent includes a semi-elliptical cross-section.

[0126]

[0148] In a 143rd aspect, the present disclosure includes the catheter of any of aspects 136 to 142, further comprising a sheath configured to be advanced distally to compress the biased stent against the catheter body.

[0127]

[0149] In a 144th aspect, the present disclosure includes the catheter of any of the 136th to 143rd aspects, wherein the actuated stent comprises nitinol, stainless steel, polyetheretherketone, polyethylene terephthalate, polyimide, or polytetrafluoroethylene.

[0128]

[0150] In a 145th aspect, the present disclosure includes a catheter of any of aspects 136 to 144, wherein the actuated stent comprises a plurality of interconnected struts, the plurality of interconnected struts comprising substantially flat ribbons having a substantially rectangular cross-section.

[0129]

[0151] In a 146th aspect, the present disclosure includes a catheter of any of aspects 136 to 145, wherein the actuated stent comprises a plurality of interconnected struts, and the plurality of interconnected struts comprises a circular cross-section.

[0130]

[0152] In a 147th aspect, the present disclosure includes the catheter of any of the 136th to 146th aspects, wherein the treatment portion is longitudinally disposed between the proximal point and the distal point.

[0153] In a 148th aspect, the present disclosure includes the catheter of any of aspects 136 to 147, wherein the distal point is positioned on the inactive side of the treatment portion.

[0131]

[0154] In a 149th aspect, the present disclosure includes a catheter of any of the 136th to 148th aspects, wherein the distal point is located proximal to the distal tip of the catheter body.

[0155] In a 150th aspect, the present disclosure includes the catheter of any of the 136th to 149th aspects, wherein the biased stent is rigidly bonded at distal and proximal points to the catheter body by an adhesive or polymer.

[0132]

[0156] In a 151st aspect, the present disclosure includes a catheter of any of aspects 136 to 150, wherein at least one of the proximal point or the distal point at least partially defines a track within the catheter body, and at least a portion of the biased stent is configured to slide within the track of the catheter body between an extended position and a low-profile position.

[0133]

[0157] In a 152nd aspect, the present disclosure includes a catheter of any of the 136th to 151st aspects, further comprising one or more magnet arrays arranged longitudinally along the catheter body.

[0134]

[0158] In a 153rd aspect, the present disclosure includes a catheter of any of aspects 136 to 152, wherein the proximal point is positioned proximal to a first end of at least one of the one or more magnetic arrays and the distal point is positioned distal to a second end of at least one of the one or more magnetic arrays, whereby the actuated stent longitudinally spans at least one of the one or more magnetic arrays.

[0135]

[0159] In a 154th aspect, the present disclosure includes a catheter of any of aspects 136 to 153, wherein at least one of the proximal point or the distal point is longitudinally disposed between a first end of at least one of the one or more magnetic arrays and a second end of at least one of the one or more magnetic arrays.

[0136]

[0160] In a 155th aspect, the present disclosure includes a method for forming a fistula between a first blood vessel and a second blood vessel, the method including the steps of advancing a first catheter into the first blood vessel, the first catheter comprising a first catheter body, an electrode, and a first biasing stent, the electrode configured to protrude from a treatment portion of the first catheter and define an active side of the first catheter, the first biasing stent configured to extend longitudinally along the length of the first catheter body and extend radially away from the first catheter body between a proximal point and a distal point, the first biasing stent extending from the inactive side of the first catheter body, thereby configuring the first biasing stent to bias the treatment portion against a wall of the first blood vessel, and ablatating tissue with the electrode to form a fistula.

[0137]

[0161] In a 156th aspect, the present disclosure includes a method according to the 155th aspect, wherein the treatment portion is positioned longitudinally between a proximal point and a distal point.

[0162] In a 157th aspect, the present disclosure includes the method of any of aspects 155 to 156, further including the steps of advancing a second catheter into the second blood vessel and aligning an electrode of the first catheter with the second catheter.

[0138]

[0163] In a 158th aspect, the present disclosure includes a method of any of aspects 155 to 157, wherein the second catheter includes a recess, and the step of aligning an electrode of the first catheter with the second catheter includes aligning the electrode with the recess.

[0139]

[0164] In a 159th aspect, the present disclosure includes the method of any of aspects 155 to 158, wherein the first catheter further comprises one or more magnet arrays arranged longitudinally along the first catheter body, and the second catheter further comprises a second catheter body and one or more magnet arrays arranged longitudinally along the second catheter body, and the electrodes of the first catheter are aligned with the second catheter via the one or more magnet arrays of the first catheter and the one or more magnet arrays of the second catheter.

[0140]

[0165] In a 160th aspect, the present disclosure includes the method of any of aspects 155 to 159, wherein the second catheter further comprises a second biasing stent, the second biasing stent configured to extend longitudinally along the length of the second catheter body and extend radially away from the second catheter body between a proximal point and a distal point, the second biasing stent extending from the inactive side of the second catheter body, whereby the second biasing stent is configured to bias the recess against the second vessel wall.

[0141]

[0166] In a 161st aspect, the present disclosure includes the method of any of the 155th to 160th aspects, wherein the recess is longitudinally disposed between the proximal point and the distal point.

[0167] These and additional features provided by the embodiments described herein will be more fully understood when the following detailed description is considered in conjunction with the drawings.

[0142]

[0168] The embodiments illustrated in the drawings are illustrative and exemplary in nature and are not intended to limit the subject matter defined by the claims. The following detailed description of illustrative embodiments can be understood when read in conjunction with the following drawings, in which like structure is indicated with like reference numerals and in which: [Brief explanation of the drawings]

[0143] [Figure 1]

[0169] 1 is an illustration of the vasculature of the arm to which endovascular treatment according to one or more embodiments shown and described herein can be delivered. [Figure 2]

[0170] FIG. 1 depicts a two-catheter system according to one or more embodiments shown and described herein. [Figure 3]

[0171] FIG. 1 depicts a single catheter system according to one or more embodiments shown and described herein. [Figure 4]

[0172] FIG. 1 is a cross-sectional view of a single catheter system in an expanded state according to one or more embodiments shown and described herein. [Figure 5A]

[0173] FIG. 1 is a cross-sectional view of a single catheter system in an expanded state according to one or more embodiments shown and described herein. [Figure 5B]

[0174] 5B is an axial cross-sectional view of the catheter of FIG. 5A deployed in a blood vessel according to one or more embodiments shown and described herein. [Figure 6]

[0175] FIG. 1 is a cross-sectional view of a single catheter system in an expanded state according to one or more embodiments shown and described herein. [Figure 7]

[0176] FIG. 1 is a cross-sectional view of a single catheter system in an expanded state according to one or more embodiments shown and described herein. [Figure 8A]

[0177] 8 is an axial cross-sectional view of the catheter of FIG. 7 having a single biasing spring according to one or more embodiments shown and described herein. [Figure 8B]

[0178] FIG. 1 is an axial cross-sectional view of a catheter having two biasing springs according to one or more embodiments shown and described herein. [Figure 8C]

[0179] FIG. 1 is an axial cross-sectional view of a catheter having three biasing springs according to one or more embodiments shown and described herein. [Figure 9]

[0180] FIG. 1 is a cross-sectional view of a single catheter system in an expanded state according to one or more embodiments shown and described herein. [Figure 10A]

[0181] 1 is a cross-sectional view of a single catheter system in an unexpanded state according to one or more embodiments shown and described herein. [Figure 10B]

[0182] FIG. 10B is a cross-sectional view of the single catheter system of FIG. 10A in an expanded state according to one or more embodiments shown and described herein. [Figure 11A]

[0183] FIG. 1 depicts a single catheter system in an unexpanded state according to one or more embodiments shown and described herein. [Figure 11B]

[0184] FIG. 11B depicts the single catheter system of FIG. 11A in an expanded state according to one or more embodiments shown and described herein. [Figure 12A]

[0185] FIG. 1 depicts a single catheter system in an unexpanded state according to one or more embodiments shown and described herein. [Figure 12B]

[0186] FIG. 1 depicts a single catheter system in an unexpanded state according to one or more embodiments shown and described herein. [Figure 13A]

[0187] FIG. 1 is a cross-sectional view of a single catheter system in an expanded state according to one or more embodiments shown and described herein. [Figure 13B]

[0188] 13B depicts the exit and re-entry points of the catheter of FIG. 13A according to one or more embodiments shown and described herein. [Figure 14A]

[0189] 13A and 13B according to one or more embodiments shown and described herein. FIG. [Figure 14B]

[0190] 14B depicts the vessels of FIG. 14A with a cutting device according to one or more embodiments shown and described herein moving from a first vessel into a second vessel and back again to the first vessel. [Figure 14C]

[0191] 14C depicts the cutting device of FIG. 14B further advanced according to one or more embodiments shown and described herein. [Figure 14D]

[0192] 14D is an axial cross-sectional view of the catheter and the first and second vessels of FIG. 14C according to one or more embodiments shown and described herein. [Figure 15]

[0193] FIG. 2 is a diagram that schematically depicts communication between various modules of a system for endovascular treatment of a blood vessel according to one or more embodiments shown and described herein. [Figure 16A]

[0194] 1 depicts a display showing endovascular treatment of a blood vessel according to one or more embodiments shown and described herein. [Figure 16B]

[0195] 16B depicts the display of FIG. 16A with an overlay according to one or more embodiments shown and described herein. [Figure 16C]

[0196] FIG. 16B depicts the display of FIG. 16A with a catheter deployed to provide intravascular treatment according to one or more embodiments shown and described herein. [Figure 16D]

[0197] FIG. 1 depicts fistula formation according to one or more embodiments shown and described herein. [Figure 17]

[0198] FIG. 2 is a diagram that schematically depicts communication between various modules of a system for endovascular treatment of a blood vessel according to one or more embodiments shown and described herein. [Figure 18]

[0199] FIG. 18 is a perspective view of the system of FIG. 17 according to one or more embodiments shown and described herein. [Figure 19A]

[0200] 1 depicts a display showing several views from an imaging device according to one or more embodiments shown and described herein. [Figure 19B]

[0201] FIG. 1 depicts a display showing a three-dimensional model of a subject's vasculature according to one or more embodiments shown and described herein. [Figure 20]

[0202] FIG. 1 illustrates a user input device according to one or more embodiments shown and described herein. [Figure 21]

[0203] 1 illustrates an endovascular treatment being performed on a subject according to one or more embodiments shown and described herein. [Figure 22]

[0204] 1 illustrates a media vessel and an imaging device according to one or more embodiments shown and described herein. [Figure 23A]

[0205] FIG. 1 is a perspective view of a media vessel and an imaging device according to one or more embodiments shown and described herein. [Figure 23B]

[0206] FIG. 23B is a front view of the media vessel and imaging device of FIG. 23A according to one or more embodiments shown and described herein. [Figure 24A]

[0207] FIG. 10 depicts a display displaying imaging data from an imaging device during vascular treatment according to one or more embodiments shown and described herein. [Figure 24B]

[0208] FIG. 10 depicts a display displaying imaging data from an imaging device during vascular treatment according to one or more embodiments shown and described herein. [Figure 24C]

[0209] FIG. 10 depicts a display displaying imaging data from an imaging device during vascular treatment according to one or more embodiments shown and described herein. [Figure 24D]

[0210] FIG. 10 depicts a display displaying imaging data from an imaging device during vascular treatment according to one or more embodiments shown and described herein. [Figure 25A]

[0211] FIG. 1 is a cross-sectional view of a single catheter system according to one or more embodiments shown and described herein. [Figure 25B]

[0212] FIG. 1 is a cross-sectional view of a single catheter system according to one or more embodiments shown and described herein. [Figure 26A]

[0213] 1 is a schematic side view of a catheter including an actuated stent according to one or more embodiments shown and described herein. [Figure 26B]

[0214] FIG. 26B is a schematic top view of the catheter of FIG. 26A according to one or more embodiments shown and described herein. [Figure 26C]

[0215] FIG. 26B is a schematic side view of a sheath advanced distally over the catheter of FIG. 26A according to one or more embodiments shown and described herein. [Figure 27A]

[0216] 26B is a schematic axial cross-sectional view of the catheter and biased stent of FIG. 26A according to one or more embodiments shown and described herein. [Figure 27B]

[0217] 26B is a schematic axial cross-sectional view of the catheter and biased stent of FIG. 26A according to one or more embodiments shown and described herein. [Figure 28A]

[0218] 1 is a schematic top view of a catheter including a biased stent and a track according to one or more embodiments shown and described herein. [Figure 28B]

[0219] 28B is a schematic cross-sectional view of the catheter of FIG. 28A with a biased stent in an extended configuration according to one or more embodiments shown and described herein. [Figure 28C]

[0220] 28B is a schematic cross-sectional view of the catheter of FIG. 28A with a biased stent in a low-profile configuration according to one or more embodiments shown and described herein. [Figure 28D]

[0221] 28B is a schematic cross-sectional view of the catheter of FIG. 28A with a biased stent in a low-profile configuration according to one or more embodiments shown and described herein. [Figure 28E]

[0222] 28B is a schematic cross-sectional view of the catheter of FIG. 28A with a biased stent in an extended configuration according to one or more embodiments shown and described herein. [Figure 29A]

[0223] FIG. 1 is a diagram that schematically depicts a two-catheter system according to one or more embodiments shown and described herein. [Figure 29B]

[0224] FIG. 1 is a diagram that schematically depicts a two-catheter system according to one or more embodiments shown and described herein. [Figure 30]

[0225] 1 is a schematic side view of another catheter including a biased stent according to one or more embodiments shown and described herein. [Figure 31]

[0226] 1 is a schematic side view of a single catheter system including an actuated stent according to one or more embodiments shown and described herein. DETAILED DESCRIPTION OF THE INVENTION

[0144]

[0227] The embodiments described herein are directed to systems, methods, and catheters for endovascular treatment of blood vessels. Endovascular treatments can include, but are not limited to, fistula formation, vasoocclusion, angioplasty, thrombectomy, atherectomy, crossing, drug-coated balloon angioplasty, stent placement (uncovered and covered), and lytic therapy. Thus, while various embodiments are directed to fistula formation between two blood vessels, other vascular treatments are contemplated and possible. These figures generally depict various systems, methods, and devices that enable an operator to visualize and determine when a catheter has reached the correct location to provide treatment to a blood vessel (e.g., to form a fistula between adjacent blood vessels). In particular, determining when a catheter has reached the desired location for treatment can be very challenging for an operator. In particular, a visualization system (e.g., ultrasound, fluoroscopy, etc.) can involve the need for equipment that can be difficult to control while also controlling the advancement of one or more catheters into a patient's vasculature. Additionally, such equipment can be expensive, and thus treatment facilities may only include such visualization systems in operating rooms, etc. Thus, the systems described herein make visualization easier and / or more accessible for a variety of applications.

[0145]

[0228] Additionally, the use of two catheters to form a fistula or otherwise provide treatment (e.g., advancing a wire from one blood vessel to another) is described in U.S. Pat. No. 9,017,323, entitled "Devices and Methods for Forming Fistula," filed November 16, 2011, which is incorporated herein by reference in its entirety; U.S. Pat. No. 9,486,276, entitled "Devices and Methods for Fistula Formation," filed October 11, 2013, which is incorporated herein by reference in its entirety; U.S. Patent Application Publication No. 2014 / 0276335, entitled "Fistula Formation Devices and Methods Therefor," filed March 14, 2014, which is incorporated herein by reference in its entirety; U.S. Patent Application Publication No. 2015 / 0258308, entitled "Methods for Forming Fistulas," filed February 9, 2016, which is incorporated herein by reference in its entirety; U.S. Patent Application Serial No. 15 / 019,962, entitled "Devices and Methods for Treating Hypertension," filed January 15, 2017, which is incorporated herein by reference in its entirety; U.S. Patent Application Publication No. 2017 / 0202616, entitled "Devices and Methods for Forming a Fistula," filed January 15, 2017, which is incorporated herein by reference in its entirety; U.S. Patent Application Publication No. 2017 / 0202603, entitled "Systems and Methods for Increasing Blood Flow," filed January 15, 2017, which is incorporated herein by reference in its entirety; U.S. Patent Application Serial No. 16 / 024,241, entitled "Systems and Methods for Adhering Vessels," filed June 29, 2018, which is incorporated herein by reference in its entirety; and U.S. Patent Application Serial No. 16 / 024,241, entitled "Devices and Methods for Adhering Vessels," filed June 29, 2018, which is incorporated herein by reference in its entirety.345. However, manipulating two catheters while simultaneously attempting to visualize the position of both catheters can be very cumbersome for the user. Accordingly, various embodiments described herein are directed to reducing the number of catheters to a single catheter while still providing visualization to allow the user to easily determine the location of the catheter treatment portion. Furthermore, catheter flexibility, vessel spacing, vessel wall thickness, and / or vessel tortuosity can make it difficult to provide sufficient intervascular coaptation and / or alignment for fistula formation. Accordingly, the embodiments described herein address one or more of the limitations discussed above.

[0146]

[0229] These and additional features are discussed in more detail below.

[0230] The vasculature of a potential subject (e.g., a patient) may be tortuous. Additionally, each subject's vasculature may vary to provide each subject with uniquely positioned blood vessels (e.g., veins and arteries). Thus, in some embodiments, prior to vascular treatment, the described systems may be used to scan the vasculature around the subject's treatment area to map the subject's vasculature and / or determine an appropriate location for treatment (e.g., fistula formation). FIG. 1 shows a simplified diagram of a typical vasculature, including one or more blood vessels that may be targeted for vascular treatment, around the elbow joint 12 of an arm 10. As shown, the brachial artery 20 extends superficially distally from the upper arm and sinks deep into the arm near the elbow joint 12; the brachial artery 20 branches into the radial artery 22 and the ulnar artery 24. The upper part of the ulnar artery 24 lies deep within the arm, beneath the flexor muscles (not shown), connecting the ulnar side of the forearm to the wrist. Further down the arm, typically just below the radial tuberosity of the radius (not shown), the interosseous arteries 26 branch off from the ulnar artery 24 and eventually join the posterior and anterior interosseous arteries (not shown).

[0147]

[0231] Also shown in FIG. 1 are the cephalic veins 40, including the brachial cephalic vein 42, the median cephalic vein 44, and the forearm cephalic vein 46, and the basilic veins 50, including the brachial basilic vein 52, the median basilic vein 54, and the forearm basilic vein 56. The brachial cephalic vein 42 runs along the lateral border of the biceps muscle (not shown) and continues into the forearm as the forearm cephalic vein 46. The median cephalic vein 44 joins the cephalic vein 40 near the elbow joint 12. The brachial basilic vein 52 runs along the medial side of the biceps muscle (not shown) and continues into the forearm as the forearm basilic vein 56. The forearm basilic vein 56 is sometimes referred to as the common ulnar vein. The median basilic vein 54 (sometimes called the median cubital vein) joins the median basilic vein of the upper arm 52 and the median basilic vein of the forearm 56. The median basilic vein 54 and the median cephalic vein 44 form at the branches of the median antebrachial vein 58. Near where the median antebrachial vein 58 branches into the median basilic vein 54 and the median cephalic vein 44, perforating branches 30 connect these vessels to the deep veins of the arm through the forearm fascia (not shown).

[0148]

[0232] As shown in FIG. 1 , the perforating branches 30 communicate with the first deep ulnar vein 23 and the second deep ulnar vein 24. These deep ulnar veins 23 / 24 can run substantially parallel to either side of the ulnar artery 22 between the brachial artery 14 and the interosseous artery 18 and can branch off from the ulnar artery 24 distal to the interosseous artery 16. Between the brachial artery 20 and the interosseous artery 26, the deep ulnar vein 23 / 24 is typically located closely adjacent to the ulnar artery 20, with the ulnar artery 22 usually being less than 2 mm from the deep ulnar vein 23 / 24. Along the length of the deep ulnar vein 23 / 24, lateral branches (not shown) may occasionally connect to the deep ulnar vein 23 / 24. Also shown in FIG. 1 are the first brachial vein 13 and the second brachial vein 15. The brachial veins 13 / 15 generally run alongside the brachial artery 14, and the deep ulnar veins 23 / 24 connect to the brachial veins 13 / 15 near the elbow joint. Additionally, a pair of radial veins 17 / 19 can run alongside the radial artery 18 and connect to one or both of the brachial veins 13 / 15.

[0149]

[0233] In various embodiments, access to the ulnar artery and / or vein can be achieved through an access site created in a superficial vein or artery from the wrist or even the arm. A catheter can then be advanced through the vasculature to the treatment location. For example, to increase blood flow from a deep artery to a superficial vein for purposes such as dialysis, it is often desirable to create a fistula between the vein and artery adjacent to a perforator (e.g., perforator 30). Advancing a catheter through a superficial vein or artery provides easier access to the site for fistula creation within the deep arterial / venous system.

[0150]

[0234] It should be noted that the vascular structure of the arm is shown for illustrative purposes only. It is contemplated that the systems described herein can be used to treat blood vessels anywhere within the body of a human or animal (e.g., cow, sheep, pig, horse, etc.). For example, in some embodiments, the targeted and treated blood vessels can include the femoral artery and femoral vein or the iliac artery and iliac vein. In other embodiments, treatment between body conduits is not limited to vein / artery treatment, but can also include treatment or fistula formation between adjacent veins, adjacent arteries, or any other body conduit (e.g., bile duct, esophagus, etc.).

[0151]

[0235] catheter

[0236] Generally, the systems described herein are directed to endovascular treatment of blood vessels. For example, the systems described herein can be useful for measuring, modifying, and / or cauterizing tissue to form a fistula. The systems described herein typically include one or more catheters. The one or more catheters can include one or more treatment segments. In the case of a fistula formation procedure, the one or more treatment segments can include one or more fistula formation elements. The described catheters can further include elements to assist in visualization and / or alignment of the one or more catheters, as described in more detail herein. Any suitable catheter or catheters can be used with the systems described herein to form other fistulas using the methods described herein.

[0152]

[0237] The catheter can have any suitable diameter for intravascular use, such as, for example, about 4 French, about 5.7 French, about 6.1 French, about 7 French, about 8.3 French, about 4 French to about 9 French, about 4 French to about 7 French, or about 4 French to about 6 French.

[0153]

[0238] Referring now to Figures 2 and 3, various embodiments of one or more catheters are depicted. Figure 2 generally illustrates one embodiment of a two-catheter system, and Figure 3 illustrates one embodiment of a single-catheter system. Thus, in embodiments incorporating a single-catheter system, a second catheter is not required to deliver the desired therapy to the blood vessel. However, it should be noted that various features of a two-catheter system or a single-catheter system can be incorporated into either of these two systems. For example, the electrodes as shown in the single-catheter system can be the same as those used in the two-catheter system.

[0154]

[0239] As mentioned above, FIG. 2 generally illustrates one embodiment of a two-catheter system configured to be used to form a fistula. As shown in FIG. 2, the system can include a first catheter 101 and a second catheter 103. The first catheter 101 can include a catheter body 105, one or more magnetic elements 107, and a treatment portion 109. As described herein, the embodiment can be directed to fistula formation, and thus the first catheter can include a fistula-forming element 110 that can be used to form a fistula. In some variations, the fistula-forming element 110 can be advanced to protrude from an opening 111 in the catheter body 105. The fistula-forming element 110 can include an electrode 106 that is configured to move between a low-profile (i.e., contoured) configuration and an extended (i.e., elongated) configuration in which the electrode 106 extends from the catheter body 105. In some variations, the fistula-forming element can be spring-biased toward the extended configuration. That is, the electrode 106 can be configured to self-expand from a low-profile configuration to an extended configuration. In other words, the electrode 106 can have a natural resting state in the extended configuration. In some variations of an electrode that moves between a low-profile configuration and an extended configuration, the electrode can be held in the low-profile configuration during catheter placement. For example, in some variations, the electrode can be held in the low-profile configuration by the catheter body. When the electrode is delivered to a location for fistula formation, the electrode can be released from the low-profile configuration. For example, in some variations, the electrode can be released by moving the electrode proximally relative to the housing using a proximal control, as described in U.S. Patent No. 9,017,323, filed November 16, 2011, entitled "Devices and Methods for Forming Fistula," which is incorporated herein by reference in its entirety.In other variations, the electrode can be held in a low-profile configuration by an external radially inward force exerted on the electrode by the vessel wall during delivery, as described in U.S. Patent Application Publication No. 2017 / 0202616, entitled "Devices and Methods for Forming a Fistula," filed January 15, 2017, which is incorporated by reference herein in its entirety.

[0155]

[0240] In some variations, the first catheter 101 can include a housing 113, which can help protect other components of the first catheter 101 during fistula formation. For example, when the fistula forming element 110 includes an electrode 106 configured to cauterize tissue, the housing 113 can include one or more insulating materials that can shield or otherwise protect one or more components of the first catheter 101 from heat that may be generated by the electrode 106 during use.

[0156]

[0241] As shown in FIG. 2 , the second catheter 103 can also include a catheter body 115 and one or more magnetic elements 107. In variations in which the first catheter 101 includes a fistula-forming element 110 configured to protrude from the catheter body 105 of the first catheter 101, such as the variation depicted in FIG. 2 , the catheter body 115 of the second catheter 103 can include a treatment portion 116 including a recess 117, which can be configured to receive the fistula-forming element 110 as it passes through tissue. While shown in FIG. 2 as having the recess 117, it should also be understood that in some variations, the treatment portion 116 of the second catheter 103 may not include the recess 117. In some variations, the treatment portion 116 of the second catheter 103 can include a fistula-forming element (not shown) in addition to or in place of the fistula-forming element 110 of the first catheter 101. Thus, in some variations, a fistula can be formed by one or more electrodes on one catheter, while in other variations, two catheters, each equipped with an electrode, can simultaneously cut tissue from both sides to form a fistula.

[0157]

[0242] In some variations, each of the one or more catheters may include one or more position indicators 119 configured to enable a control unit of the system to determine the location of the treatment portion of the catheter as the catheter is advanced through a blood vessel of a subject (e.g., a patient). For example, in one embodiment, each of the first catheter 101 and the second catheter 103 may include an echogenic marker. The echogenic marker may be positioned proximate the treatment portion of the catheter and may be visible to an imaging device of an ultrasound imaging device. The echogenic marker may form a specific pattern (e.g., a series of distinctive, spaced echogenic rings of different sizes, similar to a barcode) that may enable recognition of a particular catheter. Such a pattern or ring may include, for example, a marker band made of platinum, iridium, or a combination thereof, applied to the catheter proximate the treatment portion of the catheter. In some embodiments, as described in more detail below, a control unit that captures image data of one or more catheters using an imaging device may be configured to determine the location of the treatment portion of one or more catheters based on the echogenic markers. In a two-catheter system such as that shown in FIG. 2, each of the first and second catheters 101 / 103 can include echogenic markers, which can be identical or different. If the echogenic markers on each of the first and second catheters 101 / 103 are different, the control unit can be enabled to determine which catheter is which. In some embodiments, the echogenic markers can be used to indicate the rotational orientation of one or more catheters. For example, the pattern of echogenic markers viewed under ultrasound can indicate which direction the treatment portion of a particular catheter is facing.

[0158]

[0243] In some embodiments, in addition to or instead of echogenic markers, the catheter 101 / 103 can include one or more position sensors 121 / 123 configured to output signals indicative of the position of the catheter 101 / 103 (e.g., the treatment portion of the catheter). For example, the position sensors 121 / 123 can include active electromagnetic sensors, passive electromagnetic sensors, permanent magnets, RFID devices, and / or ultrasonic transceivers. The position sensor 121 can be coupled to or disposed within the catheter housing at a location proximate to the treatment portion of the catheter. For example, the position sensor can be disposed longitudinally within the treatment portion 109 / 116 of the catheter 101 / 103. In some embodiments, the position sensor can be disposed proximally and / or distally from the treatment portion 109 / 116 of the catheter 101 / 103. As will be described in more detail below, the control unit can determine the position of the treatment portion 109 / 116 of the catheter 101 / 103 based on signals received from the position sensor 121 and can track the position of the catheter 101 / 103 in real time with the imaging device. It should be noted that although one or more position sensors 121 / 123 are shown as being in close proximity to the treatment portion 109 / 116, one or more position sensors could also be positioned anywhere along the housing of the catheter 101 / 103.

[0159]

[0244] It should be noted that echogenic markers may have an advantage over powered position sensors because the position sensor must be connected to a power source; therefore, some echogenic markers may not require connection to a power source.

[0160]

[0245] FIG. 3 illustrates one embodiment of a system including a single catheter 200. The catheter 200 can be substantially similar to the catheter 101 described above. Like the first catheter 101 described above in connection with FIG. 2, the catheter 200 can include a housing 202, can be coupled to the housing 202, and can include a treatment portion 210. In embodiments where the endovascular treatment is directed to fistula formation, the treatment portion 210 can include an electrode 214 or other cutting device for forming the fistula. While the illustrated embodiment depicts an arcing (i.e., arcuate) electrode 214, the electrode 214 can be substantially similar to those described above and in connection with the two-catheter system. Additionally, as described above, the electrodes of the single catheter system can have features as described in U.S. Pat. No. 9,017,323, filed November 16, 2011, entitled "Devices and Methods for Forming a Fistula," which is incorporated herein by reference in its entirety, and U.S. Patent Application Publication No. 2017 / 0202616, filed January 15, 2017, entitled "Devices and Methods for Forming a Fistula," which is incorporated herein by reference in its entirety.

[0161]

[0246] It is also contemplated that catheter 200 may include one or more echogenic markers 216 and / or one or more position sensors 218, as described above in connection with FIG. 1. One or more echogenic markers 216 and one or more position sensors 218 may be positioned anywhere along housing 202 of catheter 200. For example, one or more echogenic markers 216 may be positioned proximal or distal to and / or within treatment portion 210. Similarly, one or more position sensors 218 may be positioned proximal or distal to and / or within treatment portion 210.

[0162]

[0247] Additionally, the catheter 200 can include one or more biasing mechanisms 220. The biasing mechanism 220 can be configured to contact a wall of a blood vessel and bias the treatment portion 210 of the catheter 200 into contact with the wall of the blood vessel (e.g., a target treatment location). For example, the biasing mechanism 220 can be configured to expand to contact a first radial portion of the host vessel and bias the treatment portion 210 toward a second radial portion of the host vessel opposite the first radial portion. That is, the biasing mechanism 220 can expand to move the catheter 200 laterally within the host vessel and bring the treatment portion 210 (e.g., a cutting device, an electrode, etc.) into contact with the wall of the blood vessel. In some embodiments, the force of the biasing mechanism 220 can change the shape of the blood vessel, stretching it in a direction opposite to the movement of the biasing mechanism. Thus, the one or more biasing mechanisms 220 can be any mechanism configured to move the catheter laterally within the blood vessel and bring the treatment portion of the catheter into contact with a treatment location within the blood vessel. Such biasing mechanisms 220 can be located on both sides of the housing 202 from the treatment portion 210 of the catheter 200. The biasing mechanisms 220 can include, but are not limited to, balloons, cages, expandable wires, retraction mechanisms, etc. Various embodiments of biasing mechanisms are discussed in more detail with reference to Figures 4-13B.

[0163]

[0248] In some embodiments, the catheter 200 may further include an intravascular imaging device 240 disposed within the housing 202 adjacent to the treatment portion 210. For example, the intravascular imaging device 240 may include intravascular ultrasound ("IVUS"), optical coherence tomography ("OCT"), intracardiac ultrasound ("ICE"), etc. The intravascular imaging device 240 may be configured to provide a cross-sectional image of the position of the intravascular imaging device 240. As described in more detail herein, the intravascular imaging device 240 may be used to determine the position of the catheter 200 within a blood vessel and / or the rotational alignment of the catheter 200, e.g., the treatment portion 210 of the catheter 200. The intravascular imaging device 200 may be coupled to the housing 202 at a location distal to the treatment portion 210, may be coupled to the housing 202 at a location proximal to the treatment portion 210, or may be longitudinally aligned with and / or within the treatment portion 210 of the catheter 200. In some embodiments, one or more position sensors 220 may be incorporated into or located proximate to intravascular imaging device 240. Various embodiments of intravascular imaging devices are described in more detail with reference to Figures 4-13B and 25A-25B. It should be noted that in some embodiments, an intravascular imaging device may not be present, and an external imaging device (e.g., an external ultrasound probe) may be used instead.

[0164]

[0249] Referring now to FIG. 4 , a cross section of one embodiment of a catheter 300 having a treatment portion 305 and a biasing mechanism 310 is depicted. In the depicted embodiment, the biasing mechanism 310 can be a balloon that can be controllably expanded (e.g., controllably filled with saline). In the depicted embodiment, the balloon is an asymmetric balloon 312 that extends longitudinally across the treatment portion 302 of the catheter 300 on opposite sides of the housing 302. For example, in this embodiment, the treatment portion 302 includes an electrode 303, and the asymmetric balloon 312 is positioned diametrically opposite the electrode 303. In the depicted embodiment, the catheter 300 includes the intravascular imaging device 340 described above that is positioned distal to the treatment portion (i.e., closer to the tip of the catheter). As described in more detail herein, the biasing mechanism 310, when expanded, can bias the treatment portion 305 into contact with the treatment location on the blood vessel.

[0165]

[0250] 5A and 5B show a catheter 400 similar to that shown in FIG. 4. In the embodiment shown, the catheter 400 includes a treatment portion 405 and a biasing mechanism 410. As in FIG. 4, the biasing mechanism 410 can be an asymmetric balloon 412 that extends across the treatment portion of the catheter on opposite sides of the housing 402. For example, in this embodiment, the treatment portion 405 includes an electrode 403 having an arc extending from the housing 402, and the asymmetric balloon 412 is positioned diametrically opposite the electrode 403. In the embodiment shown, the catheter 300 includes an intravascular imaging device 440 positioned within the housing 402 at a midpoint or apex 404 of the arc of the electrode 403. As described above, the intravascular imaging device 440 can output image data depicting a cross-section of the catheter at the intravascular imaging device. For example, the cross-section can be aligned with the apex 404 of the electrode 403, as shown by line BB. 5B depicts an exemplary image output on display 450 of intravascular imaging device 440, in which a cross section within blood vessel 442 is taken at apex 404 of electrode 403. Taking the cross section at apex 404 of electrode 404 may allow for the rotational alignment of the catheter to be determined based on the position of electrode apex 404 as determined by image data from intravascular imaging device 440. Furthermore, because intravascular imaging device 440 may continue to transmit during fistula formation by electrode 403, it may be possible to determine that the electrode has entered second vessel 444 from first vessel 442 and created fistula 446.

[0166]

[0251] 6 illustrates another embodiment of a catheter 500 including a first biasing mechanism 510 and a second biasing mechanism 514. The first and second biasing mechanisms can be positioned proximal to and distal from the treatment portion 405. In such an embodiment, the first and second biasing mechanisms can include balloons 512 / 516 (e.g., asymmetric balloons). However, it is contemplated that the first and second biasing mechanisms can be any of the biasing mechanisms discussed herein. Note that positioning the balloons distal and proximal to the treatment portion can also make it easier to isolate the electrodes from the fluid (e.g., saline) used to fill the balloons 512 / 516.

[0167]

[0252] Additionally, catheter 500 can include an intravascular imaging device 540. Although intravascular imaging device 540 is shown as being located distal to treatment portion 505 (e.g., electrode 503), intravascular imaging device 540 can be positioned anywhere along catheter 500.

[0168]

[0253] FIG. 7 shows another embodiment of a catheter 600 including a treatment portion 603, an intravascular imaging device 640, and a biasing mechanism 610. In such an embodiment, the biasing mechanism includes one or more expandable wires (e.g., nitinol ribbon, wire, etc.) such as a biasing spring 611 configured to bias the treatment portion 603 into contact with the blood vessel. The biasing spring 610 can be coupled to the catheter housing 602 at first and second ends 612, 614 proximal and distal to the treatment portion 603, such that the biasing spring 610 straddles the treatment portion 603 on an opposite side of the housing 602 from the treatment portion 603. In some embodiments, the biasing mechanism 610 can include a single biasing spring 611 ( FIG. 8A ), two biasing springs 611A, 611B ( FIG. 8B ), or three biasing springs 611A, 611B, 611C ( FIG. 8C ). However, a greater number of biasing springs are contemplated and possible. The biasing spring can extend radially from the housing, as shown in Figures 8A-8C.

[0169]

[0254] As mentioned above, catheter 600 can include intravascular imaging device 640. Although intravascular imaging device 640 is shown as being located distal to treatment portion 603 (e.g., electrode 605), intravascular imaging device 640 can be positioned anywhere along catheter 600.

[0170]

[0255] 9 shows another embodiment of a catheter 700 including a treatment portion 703, an intravascular imaging device 740, and a biasing mechanism 710. In such an embodiment, the biasing mechanism 700 includes a self-expanding cage 712 (e.g., a nitinol cage) coupled to the housing of the catheter 700 opposite the treatment portion 703 (e.g., electrode 705). The self-expanding cage 712 is configured to bias the treatment portion 703 into contact with the blood vessel. The self-expanding cage 712 can be coupled to the housing 702 of the catheter 700 opposite the treatment portion 703 so as to straddle the treatment portion 703.

[0171]

[0256] As mentioned above, the catheter 700 can include an intravascular imaging device 740. Although the intravascular imaging device 740 is shown as being located distal to the treatment portion 703 (e.g., the electrode 705), the intravascular imaging device 740 can be positioned anywhere along the catheter 700.

[0172]

[0257] 31 shows another embodiment of a catheter 4000 including a treatment portion 4003, an intravascular imaging device 4040, and a biasing mechanism 4010. In such an embodiment, the biasing mechanism 4010 includes a self-expanding biasing stent 4012 (described in more detail below) coupled to the housing of the catheter 4000 opposite the treatment portion 4003 (e.g., electrode 4005). The biasing stent 4012 is configured to bias the treatment portion 4003 into contact with the blood vessel. The biasing stent 4012 can be coupled to the housing 4002 of the catheter 4000 opposite the treatment portion 4003 so as to straddle the treatment portion 4003.

[0173]

[0258] As mentioned above, the catheter 4000 can include an intravascular imaging device 4040. Although the intravascular imaging device 4040 is shown as being located distal to the treatment portion 4003 (e.g., electrode 4005), the intravascular imaging device 4040 can be positioned anywhere along the catheter 4000.

[0174]

[0259] It should be noted that each of the biasing mechanism embodiments can also be placed in a non-extended position via a retractable sheath (not shown). In other embodiments, the biasing mechanism can be activated by the operator.

[0175]

[0260] 10 and 10B illustrate one embodiment of a catheter 800 including a housing 801, a retractable sheath 804, a biasing mechanism 806, and a treatment portion 808. The treatment portion 808 can include a spring-loaded electrode 810, as described above. The retractable sheath 804 can hold the spring-loaded electrode 810 in a retracted position. The biasing mechanism 806 can be coupled to the housing 801 at a position proximate to the treatment portion 808. The biasing mechanism 806 can include one or more expandable wires movable between a collapsed position and an extended position, at least a portion of the one or more expandable wires being spaced apart from the outer wall of the housing of the catheter 801. For example, in this embodiment, the biasing mechanism 806 is shown as a biasing spring 814 that is retractable to a position within the housing 801 and expandable to a position outside the housing 801 to bias the treatment portion 808 of the catheter 800. The retractable sheath 804 is configured to hold the biasing mechanism 806 in a retracted position until deployment is desired. Thus, retracting the sheath 804 can simultaneously deploy both the spring-loaded electrode 810 and the biasing spring 814.

[0176]

[0261] The catheter 800 can include an intravascular imaging device 840. Although the intravascular imaging device 840 is shown as being located distal to the treatment portion 808 (e.g., the electrode 810), the intravascular imaging device 840 can be positioned anywhere along the catheter 800.

[0177]

[0262] 11A and 11B show one embodiment of a catheter 900 including a housing 901, a treatment portion 908, and a biasing mechanism 906. In such an embodiment, the housing 901 defines one or more lumens 910 extending therethrough. A deflection (or, in other words, a deflection) wire 912 can extend through the housing 901 and be coupled to the housing 901 at a location distal to the treatment portion 908. The housing 901 can further define an opening 909, which can allow the housing 901 to deflect around the deflection wire 912. Such deflection can allow the treatment portion 908 to be biased toward a treatment location within a blood vessel. In operation, the operator can advance the catheter 900 to the treatment location while restricting movement of the deflection wire (e.g., by holding the proximal end of the deflection wire 912) and then push the housing 901 distally. 11B, such movement causes the housing 901, including the treatment portion 908 (e.g., electrode 914), to deflect away from the deflection wire 912. In other embodiments, the operator can instead limit the movement of the housing 901 and pull on the deflection wire 912 to deflect the housing 901 away from the deflection wire 912. In embodiments, the deflection wire 912 can have a greater stiffness than the housing 901.

[0178]

[0263] Catheter 900 can include an intravascular imaging device 940. Although intravascular imaging device 940 is shown as being aligned within treatment portion 908 and aligned with the apex of electrode 914, intravascular imaging device 940 can be positioned anywhere along catheter 900.

[0179]

[0264] 12A and 12B illustrate an embodiment similar to that shown in FIGS. 11A and 11B. In particular, FIGS. 12A and 12B depict a catheter 1000 including a housing 1001, a treatment portion 1008, and a biasing mechanism 1006. In such an embodiment, the housing 1001 defines one or more lumens 1010 extending therethrough. A deflection wire 1011 can extend through the housing 1001 and be coupled to the housing 1001 at a location distal to the treatment portion 1008. The housing 1001 can further define an opening 1012 by which the deflection wire 1011 can pass in and out through the housing 1001 to provide a biasing force for biasing the treatment portion 1008 into contact with the treatment location on the blood vessel. Thus, the deflection wire 1011 has a retracted configuration (shown in FIG. 12A) in which the deflection wire 1001 is disposed within the housing, and an extended configuration (shown in FIG. 12B) in which the deflection wire 1011 is disposed outside the housing.

[0180]

[0265] In some embodiments, the deflection wire 1011 can comprise a shape memory material, such that the deflection wire 1011 flexes out of the housing 1001 in its natural state. For example, the deflection wire 1011 can be a leaf spring. In such embodiments, the user can hold the deflection wire in a retracted configuration (e.g., with the sheath) and release the deflection wire 1001 once the catheter has reached the desired position. In other embodiments, the user can instead manually advance or retract the deflection wire 1011 (e.g., pull / push the proximal end of the deflection wire 1011) to retract or extend the deflection wire 1011.

[0181]

[0266] The catheter 1000 can include an intravascular imaging device 1040. Although the intravascular imaging device 1040 is shown aligned within the treatment portion 1008 and aligned with the apex of the electrode 1014, the intravascular imaging device 1040 can be positioned anywhere along the catheter 1000.

[0182]

[0267] 13A-13F show an alternative embodiment of a catheter 1100. In such an embodiment, the catheter 1100 includes a housing 1101, a treatment portion 1108, and a biasing mechanism 1106. The biasing mechanism 1106 may include any biasing mechanism, such as, for example, an asymmetric balloon, a cage, a wire, or any other deflection mechanism discussed herein. The catheter 1100 may further include an intravascular imaging device 1140.

[0183]

[0268] 13A and 13B, the housing 1101 can define a lumen 1120 extending therethrough. The lumen 1120 can define an exit point 1122 and a re-entry point within the treatment portion 1108 of the catheter 1100. A cutting device 1110 (e.g., a nitinol needle) can be advanced through the lumen 1120 from a proximal position to a distal position, with the cutting device 1110 extending through the exit point 1122 and the re-entry point 1124. The cutting device 1110 can be made of a shape memory material configured to bend upon exiting the exit point 1122 and align itself for re-entry through the re-entry point 1124. The cutting device 1110 can be an electrode or other cutting device.

[0184]

[0269] The biasing mechanism 1106 can be coupled to the housing 1101 at a location opposite the exit and re-entry points 1122 / 1124. Thus, the biasing mechanism 1106 can bias the exit and re-entry points 1122 / 1124 into contact with a treatment location within a blood vessel.

[0185]

[0270] In this embodiment, the intravascular imaging device 1140 can be positioned longitudinally within the treatment portion 1108 of the catheter 1100 between the exit and re-entry points of the housing. In other embodiments, the intravascular imaging device can be positioned longitudinally proximally or distally from the treatment portion 1108.

[0186]

[0271] 25A and 25B, yet another alternative embodiment of a catheter 2000 is schematically depicted. The catheter 2000 is substantially similar to the previously described embodiments unless otherwise noted or apparent. In particular, the catheter 2000 includes a housing 2008, a treatment portion 2013, and a biasing mechanism 2030. The biasing mechanism 2030 may include any biasing mechanism, such as, for example, an asymmetric balloon, a cage, a wire, or any other deflection mechanism discussed herein. The catheter 2000 may further include an intravascular imaging device 2040 (e.g., a solid-state intravascular ultrasound device, a mechanical intravascular ultrasound device, etc., as described above). In an embodiment, the intravascular imaging device 2040 includes a solid-state transducer array 2012 that may be positioned circumferentially (e.g., 360 degrees) around a support structure. Similar to the previously described embodiments, the treatment portion 2013 may include a fistula-forming element 2014, such as an electrode or other cutting element. For example, the fistula forming element 2014 can be a leaf spring electrode configured to extend in an arc, such as under a natural spring bias, outside the housing 2008. An electrode wire 2020 can extend from the electrode, can extend into the housing 2008, and can be coupled to an energy source.

[0187]

[0272] In the depicted embodiment, the housing 2008 is substantially similar to the embodiments described above. However, in the depicted embodiment, the housing 2008 includes a rapid exchange tip 2002 at the distal end 2004 for passage of a guidewire. The housing 2008 can be formed from any combination of polymers, such as silicone rubber, nylon, polyurethane, polyethylene terephthalate (PET), latex, thermoplastic elastomers, etc. In some embodiments, the housing 2008 can be a braided polymer. In some embodiments, the housing 2008 can define two lumens. For example, a first lumen 2050 in the housing 2008 can accommodate the electrode wires 2020 of the catheter 2000, and a second lumen 2060 of the housing 2008 can accommodate various other components, such as an intravascular imaging device 2040, a solid state transducer array 2012, components related thereto, etc. In some embodiments, the first lumen 2050 that houses the electrode wire 2020 can include an insulating sleeve that electrically and / or thermally insulates the electrode wire 2020. In some embodiments, the first lumen 2050 can be radially disposed within the second lumen 2060.

[0188]

[0273] As described above, the treatment portion 2013 of the catheter 2000 can include an electrode. The electrode can have an electrode housing 2016 disposed within the catheter 2000. The electrode housing 2016 can be disposed within the catheter housing 2008 and can be generally aligned with the treatment portion 2013. The electrode can extend radially from the catheter housing 2008 in the electrode housing 2016. The electrode can be housed within the electrode housing 2016 when the electrode is in a low-profile configuration. The electrode housing 2016 can define a channel 2026 therethrough for passing wires for an intravascular imaging device 2040, a solid-state transducer array 2012, or the like.

[0189]

[0274] The solid-state transducer array 2012 can be a piezoelectric ultrasound transducer. In some embodiments, the solid-state transducer array 2012 can extend around the entire circumference of the catheter housing 2008. In some embodiments, the solid-state transducer array 2012 can extend around a portion of the circumference of the catheter housing 2008. The solid-state transducer array 2012 can be secured within or on the catheter 2000 by any suitable method. The solid-state transducer array 2012 can be embedded within the catheter housing 2008. In other embodiments, the solid-state transducer array 2012 can be secured to the exterior surface of the catheter housing 2008. In other embodiments, the solid-state transducer array 2012 can be friction-fit within the catheter housing 2008. The solid-state transducer array 2012 can be positioned proximal or distal to the fistula forming element 2014, as discussed in more detail below.

[0190]

[0275] The solid-state transducer array 2012 can be coupled to one or more flexible circuit elements housed within the catheter housing 2008, such as, but not limited to, one or more multiplexing (i.e., multiplex transmission) integrated circuits 2022. The one or more multiplexing integrated circuits 2022 can be located within the catheter housing 2008 near the solid-state transducer array 2012. The one or more multiplexing integrated circuits 2022 can enable front-end processing of data generated by the solid-state transducer array 2012. Locating the one or more multiplexing integrated circuits 2022 within the catheter housing 2008 near the solid-state transducer array 2012 can further reduce the cables and / or wires that run through the catheter housing 2008 and back to a back-end processor and / or display device. Notably, an IVUS wire 2024 can extend proximally through the catheter housing 2008 from the solid-state transducer array 2012 and / or the one or more multiplexing integrated circuits 2022.

[0191]

[0276] In embodiments, the solid state transducer array 2012 can be disposed between the electrode housing 2016 and the distal end 2004 of the catheter 2000. That is, the solid state transducer array 2012 can be disposed between the electrode housing 2016 and the rapid exchange tip 2002. In such embodiments, one or more multiplexed application integrated circuits 2022 can be disposed between the solid state transducer array 2012 and the electrode housing 2016. A channel 2026 in the electrode housing 2016 can allow an IVUS wire 2024 to extend from the multiplexed application integrated circuit 2022, through the electrode housing 2016, and proximally through the catheter housing 2008.

[0192]

[0277] In some embodiments, the electrode housing 2016 can be disposed between the solid state transducer array 2012 and the distal end 2004 of the catheter 2000. That is, the electrode housing 2016 can be disposed between the solid state transducer array 2012 and the rapid exchange tip 2002. In such embodiments, the solid state transducer array 2012 can be disposed between one or more multiplexed application specific integrated circuits 2022 and the electrode housing 2016.

[0193]

[0278] 14A-14D illustrate a possible method for forming a fistula using the catheter 1100 shown in FIGS. 13A and 13B. In such embodiments, the catheter 1100 can be advanced through a first blood vessel 1180 (e.g., an artery or vein) to a location where the first blood vessel 1180 is disposed proximal to a second target vessel 1182 (e.g., a vein or artery). While the catheter can be advanced through either a vein or an artery, it should be noted that in some embodiments, it is beneficial to advance the catheter through an artery and form the fistula from the arterial side rather than the venous side. This is because advancing from the higher pressure of the artery to the lower pressure of the vein can provide improved fistula formation. However, in other embodiments, the catheter can be advanced to the desired location through a vein instead. In further embodiments, a first catheter can be advanced through an artery and a second catheter can be advanced through a vein, such as in the two-catheter system discussed above.

[0194]

[0279] 14A , catheter 1100 is advanced to a treatment location within a first blood vessel 1180. Based on imaging from, for example, intravascular imaging device 1140, an operator can determine that catheter 1100 is in the correct position for treatment (e.g., fistula formation between an artery and a nearby vein). Once in position, biasing mechanism 1106 can be actuated to bias a treatment portion 1108 of the catheter into contact with the treatment location (e.g., a desired portion of a vessel wall) in first blood vessel 1180. In such a case, imaging using intravascular imaging device 1140 can allow the operator to determine that treatment portion 1108 is rotationally aligned with the desired treatment location in the blood vessel. It should be noted that in some embodiments, the intravascular imaging device 1140 may include a sensor (e.g., a position sensor) that outputs an indication of the rotational alignment of the intravascular imaging device 1140, which may be correlated to an indication of the rotational alignment of the treatment portion 1108 of the catheter 1100, or such an indication may be provided in other ways.

[0195]

[0280] Once in position, the cutting device 1110 can be advanced along the lumen through the exit point 1122 and into the second blood vessel 1182. In FIG. 14B, the cutting device 1110 can be continued to be advanced, causing the cutting device 1110 to again exit the second blood vessel 1182 and enter the re-entry point 1124 of the catheter 1100. Referring to FIG. 14C, continued advancement of the cutting device 1110 can more closely sandwich the walls of the first and second blood vessels 1180 / 1182 between the cutting device 1110 and the catheter housing 1101. FIG. 14D shows image data from the intravascular imaging device 1140 that can be displayed on a display 1190 communicatively coupled to the intravascular imaging device 1140. The image data can be an axial cross-section of the catheter 1100 and blood vessels 1180 / 1182 at the location of the intravascular imaging device 1140. Such a cross section shows the biasing mechanism 1106 biasing the treatment portion 1108 of the catheter 1100 into contact with the treatment location on the blood vessel 1180. Additionally, the cutting device 1110 is shown as being positioned within the second blood vessel 1182. Thus, it can be confirmed that the cutting device has entered the second blood vessel. Once in place, the cutting device 1110 can be activated (e.g., with RF energy) to create a fistula between the first blood vessel 1180 and the second blood vessel 1182. It can be confirmed that the fistula has been created by monitoring the blood flow between the two vessels through the fistula using Doppler, fluoroscopy, or other imaging capabilities.

[0196]

[0281] Referring next to FIG. 26A , another catheter 3100 (e.g., a first catheter) of a system for forming a fistula is depicted. As described in more detail herein, the system can further include a second catheter 3400 ( FIG. 29A ). While the structure of the first catheter 3100 will be discussed in detail, it should be understood that the structure of the second catheter 3400 ( FIG. 29A ) can be similar to the first catheter 3100, except as noted. The catheter 3100 generally includes a catheter body 3102, which can include a distal tip 3140 specifically configured to assist in advancing the catheter 3100 through a blood vessel. For example, the distal tip 3140 can be sharp and / or atraumatic for advancement through a blood vessel. The catheter body 3102 can have any desired cross-sectional shape and any suitable diameter for intravascular use. The catheter 3100 may further include one or more lumens or other passageways extending at least partially along or through the catheter body 3102. For example, the one or more lumens may extend at least partially longitudinally through the catheter body 3102 in the direction of the x-axis of the coordinate axes of FIG.

[0197]

[0282] The catheter 3100 can further include a treatment portion 3135 disposed along the catheter body 3102. The treatment portion 3135, as described herein, refers to a portion of the catheter 3100 disposed along the catheter body 3102 that is configured to modify (e.g., cut, cauterize, etc.) a blood vessel. In particular, in embodiments of the present disclosure, the catheter 3100 can include a treatment portion 3135 configured to form one or more fistulas between a first blood vessel 3300 ( FIG. 29A ) and a second blood vessel 3302 ( FIG. 29A ). In embodiments, the treatment portion 3135 can be disposed along the catheter body 3102 at a location proximal to the distal tip 3140 (e.g., in the −x direction of the coordinate axes in FIG. 26A ) and can define an active side 3134. The treatment portion 3135 can include one or more openings on the active side 3134 thereof that allow one or more instruments to pass into and / or out of the catheter body 3102 to modify the vessel. For example, the active side 3134 of the treatment portion 3135 is the portion of the treatment portion 3135 that abuts or faces the area of ​​the vessel where modification is to be made. For example, an electrode 3108 can protrude from the active side 3134 of the treatment portion 3135 and extend radially away from the longitudinal centerline of the catheter 3100 to contact the wall of the blood vessel 3300 (see, e.g., FIG. 29B ).

[0198]

[0283] The electrode 3108 may include an exposed ablation surface that can be activated to ablate tissue and a lead wire or other conductor attached to the ablation surface. In particular, when activated, the electrode 3108 may supply current to and / or carry current from tissue and fluids via the ablation surface to facilitate ablation or vaporization of tissue to form a fistula. In some embodiments, the electrode 3108 may be a spring wire or leaf spring electrode and may be movable between a low-profile configuration in which the electrode 3108 is retained within the catheter 3100 and an extended configuration in which the electrode 3108 protrudes from the surface of the catheter body 3102. The electrode 3108 may or may not be naturally biased to protrude from the catheter body 3102. When the electrode 3108 is naturally biased to protrude from the catheter body 3102, a structure such as a retractable sheath 3160 may be used to hold or maintain the electrode 3108 in the low-profile configuration until deployment is desired. In some embodiments, the catheter body 3102 may include one or more insulating materials (not shown) that can shield or otherwise protect the catheter 3100 and its components from heat generated by the electrodes 3108 during use.

[0199]

[0284] 26A , the catheter 3100 includes an inactive side 3103 or region located opposite the active side 3134 of the treatment portion 3135. For example, the inactive side 3103 refers to the side of the catheter 3100 that does not include the cutting and / or cauterizing means. The inactive side 3103 of the catheter 3100 extends across the catheter body 3102 and the treatment portion 3135. In other words, both the catheter body 3102 and the treatment portion 3135 can define an inactive side 3103. The inactive side 3103 of the catheter body 3102 and the treatment portion 3135 is diametrically opposed from the active side 3134 of the treatment portion 3135. Thus, the inactive side 3103 of the catheter body 3102 and the treatment portion 3135 is located opposite the electrode 3108. In other words, the non-active side 3103 of the catheter body 3102 and treatment portion 3135 do not abut or face the modification formed in the blood vessel 3300 (FIG. 29A) via the active side 3134 of the treatment portion 3135. Instead, the non-active side 3103 of the catheter body 3102 can be spaced apart from the modification formed in the blood vessel 3300 (FIG. 29A) by the electrode 3108 by at least a diameter or height of a portion of the catheter body 3102 (e.g., in the direction of the z-axis of the coordinate axes in FIG. 26A).

[0200]

[0285] 26A , the catheter 3100 can include one or more magnet arrays disposed longitudinally along the catheter body 3102. For example, the catheter 3100 can include a first magnet array 3104 extending longitudinally along the catheter body 3102 and disposed proximal to the treatment portion 3135 (e.g., in the −x direction of the coordinate axes of FIG. 26A ). The catheter 3100 can include a second magnet array 3106 extending longitudinally along the catheter body 3102 and disposed distal to the treatment portion 3135 (e.g., in the +x direction of the coordinate axes of FIG. 26A ). In some embodiments, the second magnet array 3106 can be disposed longitudinally (e.g., in the x direction of the coordinate axes of FIG. 26A ) between the treatment portion 3135 and the distal tip 3140 of the catheter body 3102. In embodiments, the catheter 3100 may include a third magnet array 3150 positioned within the treatment portion 3135 behind (in other words, on the back side of) the active side 3134 of the treatment portion 3135, for example, immediately behind the active side 3134. More particularly, the third magnet array 3150 may be positioned along the inactive side 3103 of the treatment portion 3135 and / or may be positioned within the inactive side 3103 of the treatment portion 3135. In embodiments, the catheter 3100 may include the first magnet array 3104, the second magnet array 3106, and the third magnet array 3150 individually or in any combination. While the phrase "magnet array" is used herein, it should be understood that each of the magnet arrays 3104, 3106, and 3150 may also be configured as a single magnet along the catheter body 3102 and / or the treatment portion 3135.

[0201]

[0286] The magnet arrays 3104, 3106, and 3150 described herein may be permanent magnets including one or more hard magnetic materials, such as, but not limited to, alloys of rare earth elements (e.g., samarium-cobalt magnets or neodymium magnets such as N52 magnets) or alnico. In some variations, the magnet arrays 3104, 3106, and 3150 may include anisotropic magnets, while in other variations, the magnet arrays 3104, 3106, and 3150 may include isotropic magnets. In some variations, the magnet arrays 3104, 3106, and 3150 may be formed from compressed powder. In some variations, a portion of the magnet arrays 3104, 3106, and 3150 (e.g., a transparent backing) may include one or more soft magnetic materials, such as, but not limited to, iron, cobalt, nickel, or ferrite. It should be understood that in a system including two catheters, the first catheter 3100 or the second catheter 3400 (FIGS. 29A and 29B) can include ferromagnetic elements (i.e., elements that are attracted to but do not generate a permanent magnetic field). For example, in some variations, the first catheter 3100 can include only one or more ferromagnetic elements, and the second catheter 3400 (FIGS. 29A and 29B) can include one or more permanent magnets. In other variations, the second catheter 3400 (FIGS. 29A and 29B) can include only one or more ferromagnetic elements, and the first catheter 3100 can include one or more permanent magnets. However, in other variations, one or both of the first catheter 3100 and the second catheter 3400 (FIGS. 29A and 29B) can include any suitable combination of ferromagnetic magnets, permanent magnets, and / or other suitable types of magnets.

[0202]

[0287] In general, the dimensions of the magnetic arrays 3104, 3106, and 3150 described herein can be selected based on the size of the catheter 3100 that will carry the magnetic arrays 3104, 3106, and 3150, which in turn can be selected based on the anatomical dimensions of a selected blood vessel through which the catheter 3100 can be advanced. For example, when advancing the catheter 3100 through a blood vessel 3300 (FIGS. 29A and 29B) having an inner diameter of approximately 3 mm, it may be desirable to configure any of the magnetic arrays 3104, 3106, and 3150 to be less than approximately 3 mm in cross section at their widest point to reduce the risk of injury to the vessel wall during advancement and manipulation of the catheter 3100. Each magnet array 3104, 3106, and 3150 can have any suitable length (e.g., about 5 mm, about 10 mm, about 15 mm, about 20 mm, etc.), although it should be understood that in some cases, a longer magnet array may limit the flexibility of the catheter 3100 for maneuvering through a vessel. In some variations, the magnet arrays 3104, 3106, and 3150 can include multiple rectangular magnets. In other embodiments, each magnet of the magnet arrays 3104, 3106, and 3150 can have any suitable shape for placement inside or outside the catheter. The magnets can be cylindrical, semi-cylindrical, tubular, box-shaped, etc.

[0203]

[0288] In embodiments, the outer surfaces of the magnet arrays 3104, 3106, and 3150 can be flush or aligned with the outer surface of the catheter body 3102. In other embodiments, the magnets 3104, 3106, and 3150 can be positioned radially within the catheter body 3102 away from the outer surface of the catheter body 3102. In other embodiments, the outer surfaces of the magnet arrays 3104, 3106, and 3150 can extend a radial distance beyond the outer surface of the catheter body 3102.

[0204]

[0289] Each magnet array 3104, 3106, 3150 may be secured in or on the catheter 3100 by any suitable method. For example, in some variations, one or more of the magnet arrays 3104, 3106, and 3150 may be embedded in the catheter 3100, attached to the catheter 3100, or friction-fit to the catheter 3100.

[0205]

[0290] 26A , the catheter 3100 can further include a biased stent 3120. The biased stent 3120 can generally take any known or desired stent structure. For example, the biased stent 3120 can generally include a plurality of interconnected struts 3170. The struts 3170 can form a plurality of cells, which are generally small repeating structures of the biased stent 3120. The cells can form a plurality of rings, and adjacent rings can be attached by a connector.

[0206]

[0291] The biasing stent 3120 can extend longitudinally (e.g., along the x-axis of the coordinate axes of FIG. 26A ) along the length of the catheter body 3102. The biasing stent 3120 can arc radially away from the catheter body 3102 between a proximal point 3130 and a distal point 3132 of the catheter body 3102. The proximal point 3130 can be located proximal to a first end of at least one of the magnet arrays 3104, 3106, 3150 (e.g., in the −x direction of the coordinate axes of FIG. 26A ), and the distal point 3132 can be located distal to a second end of at least one of the magnet arrays 3104, 3106, 3150 (e.g., in the +x direction of the coordinate axes of FIG. 26A ). Thus, the biasing stent 3120 can be configured to longitudinally span at least one of the magnet arrays 3104, 3106, 3150. In other words, at least one of the first magnet array 3104, the second magnet array 3106, and the third magnet array 3150 can be disposed longitudinally (e.g., along the x-axis of the coordinate axes of FIG. 26A ) between the proximal point 3130 and the distal point 3132. In embodiments, as discussed in further detail in connection with FIGS. 29A and 29B , the biasing stent 3120 can be positioned to bias one or more of the magnet arrays 3104, 3106, 3150 against the vessel wall. In embodiments, the proximal point 3130 and / or the distal point 3132 can be disposed within the one or more magnet arrays 3104, 3106, 3150.

[0207]

[0292] In embodiments, the biased stent 3120 can extend radially from the inactive side 3103 of the catheter 3100. In other words, the proximal point 3130 and the distal point 3132 can be disposed along the inactive side 3103 of the catheter body 3102. More particularly, in embodiments, the lateral center point 3137 ( FIG. 26B ) of the biased stent 3120 can be located diametrically opposite the active side 3134 of the treatment portion 3135. The lateral center point 3137 can be a point equidistant from the lateral (e.g., along the y-axis of the coordinate system in FIG. 26B ) outer edge of the biased stent 3120. In embodiments, the treatment portion 3135 can be disposed longitudinally (e.g., along the x-axis of the coordinate system in FIG. 26A ) between the proximal point 3130 and the distal point 3132. In embodiments, as discussed in more detail with respect to Figures 29A and 29B, the biasing stent 3120 can be configured to bias the treatment portion 3135, and more specifically the active side 3134 of the treatment portion 3135, against the vessel wall.

[0208]

[0293] In embodiments, the biased stent 3120 may include a first tapered section 3121, a second tapered section 3122, and a third section 3123 longitudinally disposed between the first tapered section 3121 and the second tapered section 3122. The first tapered section 3121 may be disposed proximal to the second tapered section 3122. The first tapered section 3121 may be coupled to the catheter body 3102 at a proximal point 3124 of the first tapered section 3121. In particular, the proximal point 3124 of the first tapered section 3121 may be coupled to the catheter body 3102 at a proximal point 3130. The first tapered section 3121 may further connect to the third section 3123 of the biased stent 3120 at a distal point 3125 of the first tapered section 3121. The second tapered section 3122 can be coupled to the catheter body 3102 at a distal point 3126 of the second tapered section 3122. In particular, the distal point 3126 of the second tapered section 3122 can be coupled to the catheter body 3102 at a distal point 3132. The second tapered section 3122 can further connect to the third section 3123 of the biased stent 3120 at a proximal point 3127 of the second tapered section 3122.

[0209]

[0294] As described above, the biased stent 3120 can arc radially away from the catheter body 3102 of the catheter 3100 between the proximal point 3130 and the distal point 3132. In some embodiments, the biased stent 3120 can be fixedly attached to the catheter body 3102 at the proximal point 3130 and the distal point 3132. In other words, the proximal point 3124 of the first tapered section 3121 can be fixedly attached to the catheter body 3102 at the proximal point 3130, and the distal point 3126 of the second tapered section 3122 can be fixedly attached to the catheter body 3102 at the distal point 3132. In such embodiments, the biased stent 3120 can be fixed to the catheter body 3102 at the proximal point 3130 and the distal point 3132 by an adhesive such as a suitable polymer or glue, laser welding, heat shrink plastic wrap, or the like.

[0210]

[0295] In embodiments, the struts 3170 of the biased stent 3120 can have a circular cross-section. In embodiments, the struts 3170 of the biased stent 3120 can be flat ribbons having a substantially rectangular cross-section. In embodiments, the biased stent 3120 can be made from metal, plastic, polymer, plastic-coated metal, composites of any of the above materials, etc. For example, the biased stent 3120 can be made from nitinol, stainless steel, polyethylene terephthalate, polyetheretherketone, polytetrafluoroethylene, polyimide, etc. The biased stent 3120 can be made from a material that exhibits high radiopacity, allowing the biased stent 3120 to be visualized under fluoroscopy. The biased stent 3120 can be made from a material that exhibits shape memory and returns to a set or desired shape.

[0211]

[0296] In some embodiments, the biased stent 3120 can expand from a low-profile configuration to an extended configuration depicted in FIG. 26A. In the low-profile configuration, the biased stent 3120 can be disposed in a non-contacting or unbiased state, and the biased stent 3120 does not apply a biasing force to the wall of the blood vessel 3300 (FIG. 29A) to bias the catheter 3100 laterally within the blood vessel 3300 (FIG. 29A). In the low-profile configuration, the biased stent 3120 can remain substantially flush with the catheter body 3102 of the catheter 3100. Thus, the catheter 3100 can be advanced to a desired location within the blood vessel 3300 (FIG. 29A) without the biased stent 3120 extending radially from the catheter body 3102 and applying a biasing force to the wall of the blood vessel 3300 (FIG. 29A) to bias the catheter 3100 laterally within the blood vessel 3300 (FIG. 29A). In the extended configuration, at least a portion of the biased stent 3120 can extend radially outward from and contact the outer surface of the catheter body 3102, where at least a portion of the biased stent 3120 applies a biasing force to the wall of the blood vessel 3300 (FIG. 29A). Thus, the maximum distance that the biased stent 3120 deflects radially from the outer surface of the catheter body 3102 when in the extended configuration can be greater than the maximum distance that the biased stent 3120 deflects radially from the outer surface of the catheter body 3102 when in the low-profile configuration.

[0212]

[0297] When the biased stent 3120 is in the extended configuration, the distal point 3125 of the first tapered section 3121 is located a greater distance from the catheter body 3102 than the proximal point 3124 of the first tapered section 3121. Also, when in the extended configuration, the proximal point 3127 of the second tapered section 3122 is located a greater distance from the catheter body 3102 than the distal point 3126 of the second tapered section 3122. Thus, when the biased stent 3120 is in the extended configuration, the first tapered section 3121 slopes from the catheter body 3102 toward the third section 3123 of the biased stent 3120, and the second tapered section 3122 slopes from the catheter body 3102 toward the third section 3123 of the biased stent 3120. In embodiments, the radially outer edge 3142 of the first tapered section 3121 can be linearly sloped from the inactive side 3103 of the catheter body 3102 to the radially outer edge 3146 of the third section 3123 of the biased stent 3120, and the radially outer edge 3144 of the second tapered section 3122 can be linearly sloped from the inactive side 3103 of the catheter body 3102 to the radially outer edge 3146 of the third section 3123 of the biased stent 3120. The sloped first and second tapered sections 3121, 3122 can allow the catheter 3100 to be advanced and retracted within the blood vessel 3300 ( FIG. 29A ) with the biased stent 3120 exposed and without causing undue stress to the vessel wall.

[0213]

[0298] In embodiments, the biased stents 3120 described herein can be biased toward an extended configuration. That is, the biased stents 3120 can be configured to self-expand from a low-profile configuration to an extended configuration. In other words, the biased stents 3120 can have a natural resting state in an extended configuration, extending a predetermined distance away from the outer surface of the catheter body 3102. In such embodiments, a force may be required to hold the biased stent 3120 in the low-profile configuration. For example, with reference to FIGS. 26A-26C, the sheath 3160 can be advanced distally (e.g., in the +x direction of the coordinate axes of FIGS. 26A-26C) to maintain the biased stent 3120 in the low-profile configuration. 26C , the sheath 3160 can include a lumen having a larger diameter than the catheter body 3102 and one or more magnet arrays 3104, 3106, 3150 of the catheter 3100, thereby allowing the sheath 3160 to be advanced distally over the catheter body 3102 and one or more magnet arrays 3104, 3106, 3150. Thus, with the sheath 3160 advanced distally over the catheter body 3102 and one or more magnet arrays 3104, 3106, 3150, the biased stent 3120 can be compressed against the catheter body 3102 by the sheath 3160. In other words, the biased stent 3120 can be compressed and maintained in a low-profile configuration within the space between the catheter body 3102 and the sheath 3160. For example, catheter 3100 within sheath 3160 can be advanced within blood vessel 3300 (FIG. 29A) to a desired location to create a fistula, at which point sheath 3160 can be retracted proximally (e.g., in the −x direction of the coordinate axes of FIGS. 26A-26C), thereby exposing biased stent 3120. When sheath 3160 is no longer applying a force to biased stent 3120 to maintain it in the low-profile configuration, the natural bias of biased stent 3120 can naturally expand it into the extended configuration shown in FIG.

[0214]

[0299] In some embodiments, the biased stent 3120 can be made from a shape memory alloy, such as copper-aluminum-nickel and nickel-titanium, that changes shape in response to environmental factors such as temperature. For example, the activated state shape of the biased stent 3120 can be the extended configuration depicted in FIG. 26A. The transition temperature of the shape memory alloy can be above standard room temperature. In some embodiments, the transition temperature of the shape memory alloy can be approximately body temperature. Thus, outside a patient's body at standard room temperature, the biased stent 3120 can be transformed into a low-profile configuration in which it is non-contact and does not extend radially away from the outer surface of the catheter body 3102 to apply a biasing force to the wall of the blood vessel 3300 (FIG. 29A). As the temperature of the biased stent 3120 increases, the biased stent 3120 may naturally transition from a low-profile configuration to an extended configuration in which the biased stent 3120 comes into contact with and extends radially away from the outer surface of the catheter body 3102, applying a biasing force to the wall of the blood vessel 3300 (FIG. 29A) to bias the catheter 3100 laterally within the blood vessel 3300 (FIG. 29A). In embodiments, the biased stent 3120 may transition from a low-profile configuration to an extended configuration at temperatures above 30° C., above 32° C., above 35° C., and similar temperatures between standard room temperature of 20° C. and body temperature of 37° C.

[0215]

[0300] 27A and 27B, cross sections of the catheter 3100 are depicted. These cross sections are particularly taken through the catheter body 3102 and the third section 3123 of the biasing stent 3120. As depicted in FIG. 27A, in embodiments, the biasing stent 3120 can have a semi-oval cross section. The biasing stent 3120 can form a semi-oval cross section, particularly when in an extended configuration. As depicted in FIG. 27B, in other embodiments, the biasing stent 3120 can have an oval cross section.

[0216]

[0301] In some embodiments, the biased stents 3120 described herein can be configured such that the biased stents 3120 are movable longitudinally (e.g., along the x-axis in FIG. 28A ) along the catheter body 3102 of the catheter 3100. For example, with reference to FIGS. 28A-28C , the biased stent 3120 can be slidable within a track 3200. The track 3200 can be an opening in the outer surface of the catheter body 3102. In embodiments, the biased stent 3120 can extend from the track 3200 in the catheter body 3102 at a proximal point 3130. That is, the proximal point 3130 can define at least a portion of the track 3200 in the catheter body 3102. More particularly, the proximal point 3130 can define a distal end of the track 3200. The biased stent 3120 is movable within the track 3200 along the catheter body 3102 from a proximal point 3130 proximally (eg, in the −x direction of the coordinate axes of FIGS. 28A-28C).

[0217]

[0302] A proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 can be positioned within and slide within the track 3200. In embodiments, the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 can include or be coupled to an anchor member 3210. The anchor member 3210 can be sized and shaped such that the anchor member 3210 can slide within the track 3200 and cannot exit the track 3200. That is, the anchor member 3210 can be unable to exit the track 3200 and extend radially away from the outer surface of the catheter body 3102.

[0218]

[0303] In the low-profile configuration, as depicted in Figure 28C, the anchor member 3210 and the proximal point 3124 of the first tapered section 3121 (Figure 26A) can be disposed at the proximal end of the track 3200. The anchor member 3210 and the proximal point 3124 of the first tapered section 3121 (Figure 26A) can be moved distally within the track 3200 to the distal end of the track 3200, as depicted in Figure 28B, thereby extending the biased stent 3120 radially away from the catheter body 3102 between the proximal point 3130 and the distal point 3132 into the extended configuration.

[0219]

[0304] In embodiments, the biased stent 3120 can be biased into the extended configuration. In other words, the anchor members 3210 and the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 can be biased to slide distally within the track 3200. The sheath 3160 can maintain the biased stent 3120 in a low-profile configuration. For example, the sheath 3160 can be advanced distally (e.g., in the +x direction of the coordinate axes of FIGS. 28A-28C ) over the catheter 3100. The sheath 3160 can apply an inward force to the biased stent 3120, compressing it, causing the anchor members 3210 and the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 to slide proximally (e.g., in the −x direction of the coordinate axes of FIGS. 28A-28C ) within the track 3200. The sheath 3160 can further prevent the anchor member 3210 and the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 from sliding distally within the track 3200. Thus, the anchor member 3210 and the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 can be maintained at the proximal end of the track 3200, and the biased stent 3120 can be maintained in a low-profile configuration. Furthermore, removing the sheath 3160 proximally (e.g., in the −x direction of the coordinate axes of FIGS. 28A-28C ) can allow the anchor member 3210 and the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 to slide distally within the track 3200 to the distal end of the track 3200, or in other words, to the proximal point 3130 of the catheter body 3102. Thus, the biased stent 3120 can assume the expanded configuration depicted in Figure 28B.

[0220]

[0305] It should be appreciated that in embodiments, the biased stent 3120 can be anchored to the catheter body 3102 at a distal point 3132 and can slide within the track 3200 from a proximal point 3130. In other embodiments, the biased stent 3120 can similarly be anchored to the catheter body 3102 at a proximal point 3130 and can slide within the track 3200 from a distal point 3132. In such embodiments, the distal point 3132 can define at least a portion of the track 3200 within the catheter body 3102. More particularly, the distal point 3132 can define a proximal end of the track 3200. The biased stent 3120 can move within the track 3200 distally (e.g., in the +x direction of the coordinate axes of FIGS. 28A-28C ) along the catheter body 3102 from the distal point 3132. In such embodiments, the biased stent 3120 can operate as described above because the biased stent 3120 can transition between a low-profile configuration and an extended configuration depending on the location of the anchor member 3210 and the distal point 3126 ( FIG. 26A ) of the second tapered section 3122 within the track 3200. In some embodiments, the biased stent 3120 can slide within the first track 3200 from a proximal point 3130 and can slide within the second track 3200 from a distal point 3132.

[0221]

[0306] In the discussed catheter 3100 embodiment, the natural bias of the biased stent 3120 can eliminate the need for a user-actuated control that holds the biased stent 3120 in a low-profile configuration for delivery through the vasculature in a first state and allows the biased stent 3120 to enter an extended configuration for applying a biasing force to the wall of the blood vessel 3300 ( FIG. 29A ) in a second state. While the biased stent 3120 can be movable between the low-profile and extended configurations, this movement can occur as a natural result of a combination of the bias of the biased stent 3120 and an external force (such as from the sheath 3160), such that the biased stent 3120 remains in a single state throughout use. That is, both during advancement of the catheter 3100 through the vasculature and ablation of tissue, the catheter 3100 is in a state that allows the biased stent 3120 to assume the extended configuration without an external force compressing the biased stent 3120. The shape memory of the biased stent 3120 and the natural bias of the biased stent 3120 allow the biased stent 3120 to return to a set shape (e.g., an extended configuration). Thus, the angle, shape, curvature, and distance of radial extension of the biased stent 3120 from the catheter body 3102 in the extended configuration can be specifically selected. The distance of radial extension of the biased stent 3120 from the catheter body 3102 can be specifically selected and / or configured based on the size of the catheter 3100 and the size of the blood vessel 3300 ( FIG. 29A ) through which the catheter 3100 is advanced. For example, the distance of radial extension of the biased stent 3120 can be selected to bias the catheter 3100 against a vessel wall in a blood vessel having a diameter of about 2 mm to about 4 mm, greater than 4 mm, greater than 6 mm, greater than 8 mm, about 10 mm, etc.

[0222]

[0307] 28D and 28E , in some embodiments, the biased stent 3120 can be user-operated from a low-profile configuration to an extended configuration. For example, in embodiments in which the biased stent 3120 is slidable within the track 3200, the anchor member 3210 can be coupled to a rod 3220. The rod 3220 can extend proximally (e.g., in the −x direction of the coordinate axes in FIGS. 28D and 28E ) through a lumen of the catheter body 3102 to a hand control (i.e., a manual control member), switch, actuator, or other user-operated device coupled to the rod 3220. The track 3200 can include an opening at its proximal end to allow the rod 3220 to be advanced through the track 3200. The opening at the proximal end of the track 3200 can be sized such that the anchor member 3210 cannot move through the opening. By actuating the user-operated device, the user can advance the anchor member 3210 and the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 distally (e.g., in the +x direction of the coordinate axes of FIGS. 28D and 28E ) within the track 3200 and / or retract the anchor member 3210 and the proximal point 3124 ( FIG. 26A ) of the first tapered section 3121 proximally (e.g., in the −x direction of the coordinate axes of FIGS. 28D and 28E ) within the track 3200. In such embodiments, the biased stent 3120 can be secured to the catheter body 3102 at a distal point 3132. Thus, by retracting the anchor member 3210 within the track 3200, the biased stent 3120 can be collapsed into a low profile configuration as shown in FIG. 28D, and by advancing the anchor member 3210 within the track 3200, the biased stent 3120 can be expanded into an extended configuration as shown in FIG. 28E.

[0223]

[0308] 29A and 29B, systems and methods for forming a fistula between a first blood vessel 3300 and a second blood vessel 3302 with a first catheter 3100 and a second catheter 3400 will now be discussed. Referring first to FIG. 29A, a first catheter 3100 can be advanced within the lumen of the blood vessel 3300. A second catheter 3400 can be positioned within a blood vessel 3302 adjacent to the blood vessel 3300. The second catheter 3400 can be similar to the first catheter 3100 discussed herein. In some embodiments, the second catheter 3400 can not include an electrode 3108. The second catheter 3400 includes a catheter body 3402. The catheter body 3402 further defines a treatment portion 3435 having an active side 3434. The second catheter 3400 further includes an inactive side 3403 defined by a catheter body 3402 and a treatment portion 3435. Specifically, the active side 3434 of the treatment portion 3435 may include a recess 3408 configured to receive the electrode 3108 of the first catheter 3100. The recess 3408 may be particularly shaped, sized, etc. to receive the electrode 3108 of the first catheter 3100 therein. In other embodiments, the second catheter 3400 may include an electrode extending radially from the treatment portion 3435 away from the catheter body 3402. The second catheter body 3402 of the second catheter 3400 may further include one or more magnet arrays. For example, the second catheter 3400 may include a first magnet array 3404 positioned proximally (e.g., in the −x direction of the coordinate axes of FIGS. 29A and 29B ) relative to the treatment portion 3435, a second magnet array 3406 positioned distally (e.g., in the +x direction of the coordinate axes of FIGS. 29A and 29B ) relative to the treatment portion 3435, and / or a third magnet array 3450 positioned along the treatment portion 3435, particularly in some embodiments along the non-active side 3403 of the treatment portion 3435. In embodiments, the second catheter 3400 may include a second biasing stent 3420 that is similar in structure and operation to the first biasing stent 3120 of the first catheter 3100.In the embodiments described below, the first catheter 3100 includes a first biasing stent 3120 and the second catheter 3400 includes a second biasing stent 3420, but it should be understood that only one of the first catheter 3100 and the second catheter 3400 may include a biasing stent.

[0224]

[0309] The one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 can be configured to facilitate rotational and axial alignment of the catheters 3100 and 3400. Proper axial and rotational alignment between the catheters 3100 and 3400 can facilitate alignment of one or more fistula forming elements, such as the treatment portions 3135, 3435 of the first and second catheters 3100, 3400, respectively. More specifically, proper axial and rotational alignment between the first catheter 3100 and the second catheter 3400 can facilitate alignment of the electrode 3108 relative to the recess 3408. The one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 can be positioned so that the magnetic field generated by the one or more magnet arrays 3104, 3106, 3150 is stronger in the direction of the active side 3134 of the treatment portion 3135 (e.g., the -z direction of the coordinate axes in Figures 29A and 29B) than in the direction of the inactive side 3103 of the treatment portion 3135 (e.g., the +z direction of the coordinate axes in Figures 29A and 29B). Similarly, the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 can be positioned such that the magnetic field generated by the one or more magnet arrays 3404, 3406, 3450 is stronger in the direction of the active side 3434 of the treatment portion 3435 (e.g., in the +z direction of the coordinate axes of FIGS. 29A and 29B ) than in the direction of the non-active side 3403 of the treatment portion 3435 (e.g., in the −z direction of the coordinate axes of FIGS. 29A and 29B ). In such an embodiment, the strength of the magnetic field in the direction of the active sides 3134, 3434 of the treatment portions 3135, 3435, respectively, can facilitate rotational alignment between the active side 3134 of the treatment portion 3135 of the first catheter 3100 in the first blood vessel 3300 and the active side 3434 of the treatment portion 3435 of the second catheter 3400 in the second blood vessel 3302.

[0225]

[0310] The catheters 3100 and 3400 are axially misaligned, as depicted in Figure 29A, such that the electrode 3108 of the first catheter 3100 is not aligned with the recess 3408 of the second catheter 3400 in the x-direction of the coordinate axis of Figures 29A and 29B. Furthermore, as depicted in Figure 29A, for example, the bond between the first catheter 3100 and the second catheter 3400 is weak. When the bond is weak, a space may remain between at least one of the active side 3134 of the treatment portion 3135 of the first catheter 3100 and the adjacent wall of the blood vessel 3300 and the active side 3434 of the treatment portion 3435 of the second catheter 3400 and the adjacent wall of the blood vessel 3302. Thus, when the bond is weak, the active side 3134 of the treatment portion 3135 and the active side 3434 of the treatment portion 3435 are not in close proximity to each other (eg, in the direction of the z-axis of the coordinate axes of Figures 29A and 29B).

[0226]

[0311] Each magnet array 3404, 3406, 3450 of the second catheter 3400 can be configured to mate with a corresponding magnet array 3104, 3106, 3150 of the first catheter 3100, or vice versa, thereby aligning and coapting the first catheter 3100 and the second catheter 3400. As used herein, the terms "coapted" and / or "strong coaptation" may be understood to mean that the first catheter 3100 and the second catheter 3400 are in close approximation (e.g., in the direction of the z-axis of the coordinate axes in FIGS. 29A and 29B ) such that the electrode 3108 of the first catheter 3100 can enter the recess 3408 of the second catheter 3400. The term "mate," as used herein, may be understood to mean a mutual attraction between the magnet array of the first catheter 3100 and the magnet array of the second catheter 3400. For example, a first magnet array 3104 disposed proximal to the treatment portion 3135 of the catheter 3100 (e.g., in the -x direction of the coordinate axes in FIGS. 29A and 29B ) can be configured to mate with a first magnet array 3404 disposed proximal to the treatment portion 3435 of the second catheter 3400 (e.g., in the -x direction of the coordinate axes in FIGS. 29A and 29B ). A second magnet array 3106 disposed distal to the treatment portion 3135 of the catheter 3100 (e.g., in the +x direction of the coordinate axes in FIGS. 29A and 29B ) can be configured to mate with a second magnet array 3406 disposed distal to the treatment portion 3435 of the second catheter 3400 (e.g., in the +x direction of the coordinate axes in FIGS. 29A and 29B ). Similarly, a third magnet array 3150 positioned along the inactive side 3103 of the treatment portion 3135 of the first catheter 3100 can be configured to mate with a third magnet array 3450 positioned along the inactive side 3403 of the treatment portion 3435 of the second catheter 3400.It will be understood that the third magnet array 3150 of the first catheter 3100 and the third magnet array 3450 of the second catheter 3400 can be configured and arranged to promote bonding between the active side 3134 of the treatment portion 3135 and the active side 3434 of the treatment portion 3435 when mated, while the third magnet array 3150 and the third magnet array 3450 can remain separated by the treatment portions 3135, 3435 (e.g., in the direction of the z-axis of the coordinate axes in Figures 29A and 29B).

[0227]

[0312] However, during a fistula formation procedure, one or more magnet arrays 3104, 3106, and 3150 of the first catheter 3100 and one or more magnet arrays 3404, 3406, and 3450 of the second catheter 3400 may not be sufficient by themselves to align and join the first catheter 3100 and the second catheter 3400. For example, limited strength of the one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400, limited flexibility of the first catheter 3100 and the second catheter 3400, the distance between the vessels 3300 and 3302, and / or the tortuous anatomical structure of the first blood vessel 3300 and / or the second blood vessel 3302 may prevent the one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 from mating. Thus, as depicted in FIG. 29A , the first catheter 3100 and the second catheter 3400 may become axially misaligned and / or may exhibit a weak bond.

[0228]

[0313] The biasing stent 3120 of the first catheter 3100 and / or the biasing stent 3420 of the second catheter 3400 can assist the one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 in aligning and joining the first catheter 3100 and the second catheter 3400. For example, with reference to FIG. 29A , the first catheter 3100 and the second catheter 3400 can be advanced into the blood vessels 3300 and 3302 with the biasing stent 3120 and / or the biasing stent 3420, respectively, in a low-profile configuration to facilitate distal advancement of the catheters 3100 and 3400 (e.g., in the +x direction of the coordinate axes of FIGS. 29A and 29B ). The biased stent 3120 of the first catheter 3100 and / or the biased stent 3420 of the second catheter 3400 can be maintained in a low-profile configuration, for example, by any of the methods discussed above in connection with Figures 26A-26C and 28A-28E. With the biased stent 3120 of the first catheter 3100 and / or the biased stent 3420 of the second catheter 3400 in the low-profile configuration, the first catheter 3100 and the second catheter 3400 can be advanced into the blood vessels 3300 and 3302, respectively, after which the treatment portion 3135 of the first catheter 3100 and the treatment portion 3435 of the second catheter 3400 are generally positioned at the desired site for forming a fistula between the blood vessels 3300 and 3302. However, as described above and depicted in FIG. 29A, the one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 may not be able to align and join the catheters 3100 and 3400 by themselves.

[0229]

[0314] 29B , the biased stent 3120 of the first catheter 3100 and / or the biased stent 3420 of the second catheter 3400 can be transitioned from a low-profile configuration to an extended configuration to facilitate alignment and docking between the first catheter 3100 and the second catheter 3400. In some embodiments, only the biased stent 3120 of the first catheter 3100 can be transitioned from a low-profile configuration to an extended configuration to facilitate alignment and docking between the first catheter 3100 and the second catheter 3400. In some embodiments, only the biased stent 3420 of the second catheter 3400 can be transitioned from a low-profile configuration to an extended configuration to facilitate alignment and docking between the first catheter 3100 and the second catheter 3400. In embodiments, biased stent 3120 and / or biased stent 3420 may be transitioned from the low-profile configuration to the extended configuration by any of the devices or methods discussed with reference to Figures 26A-26C and 28A-28E.

[0230]

[0315] In embodiments in which the biased stents 3120 and 3420 are naturally biased from the low-profile configuration to the extended configuration, the biased stents 3120 and 3420 can begin to extend radially away from the catheter bodies 3102 and 3402, respectively. For example, the biased stent 3120 can extend toward its maximum height in the extended configuration until the biased stent 3120 contacts the wall of the blood vessel 3300. The biased stent 3120 can thus apply a biasing force against the wall of the blood vessel 3300, resulting in a counter-bias force being applied to the catheter 3100, pressing the active side 3134 and / or one or more magnetic arrays against the wall of the blood vessel 3300. More specifically, because the lateral center point 3137 (FIG. 26B) of the biased stent 3120 is located directly opposite the active side 3134 of the treatment portion 3135, the biasing reaction force can guide the active side 3134 of the treatment portion 3135 against the wall of the blood vessel 3300 at a position directly opposite the lateral center point 3137 (FIG. 26B) of the biased stent 3120.

[0231]

[0316] Similarly, the biased stent 3420 of the second catheter 3400 can transition to the extended configuration and contact the wall of the second blood vessel 3302, such that a biasing reaction force guides the active side 3434 of the treatment portion 3435 of the second catheter 3400 against the wall of the second blood vessel 3302. For example, the biased stent 3420 of the second catheter 3400 can be deployed when the active side 3434 of the treatment portion 3435 of the second catheter 3400 is substantially aligned with the active side 3134 of the treatment portion 3135 of the first catheter 3100. Thus, the biased stents 3120 and 3420 can strengthen the bond between the first catheter 3100 and the second catheter 3400. For example, as described above, the biasing stent 3120 of the first catheter 3100 can bias one or more magnet arrays 3104, 3106, 3150 against the wall of the first blood vessel 3300 in addition to the active side 3134 of the treatment portion 3135, and the biasing stent 3420 of the second catheter 3400 can bias one or more magnet arrays 3404, 3406, 3450 against the wall of the second blood vessel 3302 in addition to the active side 3434 of the treatment portion 3435, thereby increasing the attractive force between the one or more magnet arrays 3104, 3105, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 by reducing the distance therebetween. For example, after close proximity, the one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 can mate, overcoming any of the aforementioned barriers such as the distance between the magnets, the flexibility of the catheters 3100, 3400, the distance between the vessels 3300, 3302, the tortuous anatomical structures of the first and second blood vessels 3300, 3302, etc. The mating of the one or more magnet arrays 3104, 3106, 3150 of the first catheter 3100 and the one or more magnet arrays 3404, 3406, 3450 of the second catheter 3400 can join and align the catheters 3100 and 3400.After the first catheter 3100 and the second catheter 3400 are joined and aligned, the electrode 3108 can be advanced and energized to ablate the walls of the first blood vessel 3300 and the second blood vessel 3302 and advanced into the recess 3408 of the second catheter 3400, thereby forming a fistula between the first and second blood vessels 3300, 3302.

[0232]

[0317] In other embodiments, only one of the catheters 3100, 3400 may be used in a method for forming a fistula between a first blood vessel 3300 and a second blood vessel 3302. For example, a contrast agent may be injected into the second blood vessel 3302 so that the second blood vessel 3302 can be viewed under fluoroscopy. The first catheter 3100 may then be advanced into the first blood vessel 3300, after which the treatment portion 3135 is generally aligned with the desired site for forming a fistula between the first and second blood vessels 3300, 3302. The biased stent 3120 may be made from a material that exhibits high radiopacity, allowing the biased stent 3120 of the first catheter 3100 to be visualized under fluoroscopy, thereby assisting a user in identifying the location of the biased stent 3120 and the treatment portion 3135 of the first catheter 3100 within the first blood vessel 3300. The biased stent 3120 of the first catheter 3100 can be transitioned from the low-profile configuration to the extended configuration by any of the devices or methods discussed with reference to Figures 26A-26C and 28A-28E. In doing so, the biased stent 3120 of the first catheter 3100 can bias the active side 3134 of the treatment portion 3135 against the wall of the first blood vessel 3300 at a desired location to form a fistula between the first blood vessel 3300 and the second blood vessel 3302. The electrode 3108 can then be advanced and energized to ablate the wall of the first blood vessel 3300 and the wall of the second blood vessel 3302, thereby forming a fistula between the first and second blood vessels 3300, 3302.

[0233]

[0318] Referring next to FIG. 30, a side view of a catheter 3500 is depicted. The catheter 3500 can be similar to the catheter 3100 discussed in FIGS. 26A-29B in all aspects except those discussed herein. For example, like the catheter 3100, the catheter 3500 can include a catheter body 3102 defining a treatment portion 3135 and one or more magnet arrays 3104, 3106, 3150. The treatment portion 3135 can include an active side 3134 diametrically opposed to an inactive side 3103. The catheter 3500 includes an actuated stent 3120 that can arc radially away from the catheter body 3102 between a proximal point 3130 and a distal point 3132. Unlike the catheter 3100 discussed above, the distal point 3132 of the catheter 3500 can be positioned along the inactive side 3103 of the treatment portion 3135. In such an embodiment, the first magnet array 3104 may be positioned between a proximal point 3130 and a distal point 3132. In an embodiment, the distal point 3132 may be positioned longitudinally (e.g., in the direction of the x-axis of the coordinate axes of FIG. 30 ) along the third magnet array 3150. In an embodiment, the position of the distal point 3132 and / or the position and / or length of the third magnet array 3150 may be adjusted such that the third magnet array 150 is positioned between the proximal point 3130 and the distal point 3132 (e.g., in the direction of the x-axis of the coordinate axes of FIG. 30 ). In some embodiments, the proximal point 3130 can be located along the inactive side 3103 of the treatment portion 3135, and the distal point 3132 can be located at the proximal end of the distal tip 3140 (e.g., in the −x direction of the coordinate axes of FIG. 30 ) such that the second magnet array 3106 is located between the proximal point 3130 and the distal point 3132. In such embodiments, the third magnet array 3150 can be located between the proximal point 3130 and the distal point 3132.Similar to catheter 3100, the biased stent 3120 of catheter 3500 may be coupled to the catheter body 3102 at a proximal point 3130 or may be movable within a track of the catheter body 3102, and the biased stent 3120 may be coupled to the catheter body 3102 at a distal point 3132 or may be movable within a track of the catheter body 3102.

[0234]

[0319] Systems and methods

[0320] Various systems and methods, including various embodiments of the catheters described above, are now described. Note that only specific embodiments may be shown in the drawings. The systems and methods may be applicable to any of the catheter systems described herein.

[0235]

[0321] 15 generally depicts communication between various modules in a system 1200 for endovascular treatment of a blood vessel. In particular, system 1200 includes a communication path 1202, a control unit 1204, an imaging device 1206, and a display 1240. It should be noted that in various embodiments, fewer or more modules may be included in system 1200 without departing from the scope of the present disclosure. In addition, the system may include one or more catheters, such as any of the two-catheter or single-catheter systems described above herein. That is, the system may include a single-catheter system configured to create a fistula or deliver another type of vascular treatment to a target location within a vessel, or a two-catheter system configured to create a fistula or deliver some other type of vascular treatment between the two catheters.

[0236]

[0322] The various modules of system 1200 can be communicatively coupled to one another via communication paths 1202. Communication paths 1202 can be formed from any medium capable of transmitting a signal, such as, for example, conductive wires, conductive traces, optical waveguides, etc. Additionally, communication paths 1202 can be formed from a combination of media capable of transmitting a signal. In some embodiments, communication paths 1202 include a combination of conductive traces, conductive wires, connectors, and buses that cooperate to enable transmission of electrical data signals between various of components such as processors, memories, sensors, input devices, output devices, and communication devices. Additionally, it should be noted that the term “signal” refers to a waveform (e.g., electrical, optical, magnetic, mechanical, or electromagnetic), such as DC, AC, sine wave, triangular wave, square wave, vibration, etc., capable of traveling through a medium.

[0237]

[0323] The control unit 1204 can be any type of computing device and includes one or more processors and one or more memory modules. The one or more processors can include any device capable of executing machine-readable instructions stored on a non-transitory computer-readable medium, such as those stored in one or more memory modules. Thus, each of the one or more processors can include a controller, an integrated circuit, a microchip, a computer, and / or any other computing device.

[0238]

[0324] The one or more memory modules of the control unit 1204 are communicatively coupled to the one or more processors. The one or more memory modules may be configured as volatile and / or non-volatile memory and, as such, may include random access memory (including SRAM, DRAM, and / or other types of RAM), flash memory, secure digital (SD) memory, registers, compact discs (CDs), digital versatile discs (DVDs), and / or other types of non-transitory computer-readable media. Depending on the particular embodiment, these non-transitory computer-readable media may reside within the control unit 1304 as shown and / or may be located external to the control unit 1304. The one or more memory modules may be configured to store logic (i.e., machine-readable instructions) that, when executed by the one or more processors, enables the control unit to perform various functions, as described in more detail below.

[0239]

[0325] The imaging device 1206 may be any imaging device configured to capture image data of one or more catheters and surrounding vascular structures as the catheter advances through a blood vessel. For example, as described above, the imaging device 1306 may be an intravascular imaging device (e.g., IVUS, ICE, OCT, etc.) coupled to a housing of the catheter. Intravascular imaging devices are described in more detail above. In other embodiments, the imaging device 1306 may be an external imaging device, such as, for example, an ultrasound device (e.g., a 2D ultrasound device and / or a 3D ultrasound device).

[0240]

[0326] The imaging device 1206 can be communicatively coupled to a control unit via a communication path. Based on data received from the imaging device 1306, the control unit can process the image data to enable determining the rotational orientation of the catheters, more specifically the rotational orientation of the treatment portions of the catheters. In a two-catheter system, the control unit can enable determining the proper alignment (e.g., longitudinal, rotational, and distance) between the two catheters for delivery of the vascular treatment.

[0241]

[0327] As described above, system 1200 further includes a display 1240 communicatively coupled to the other modules of system 1200 via communication path 1202. Display 1240 can be any type of display configured to display image data from imaging device 1206. In some embodiments, control unit 1204 can process the image data and project indicia onto the image via the display to indicate, for example, rotational alignment, longitudinal alignment, distance between vessels, vessel labels (artery, catheter, perforator, etc.), etc. In embodiments in which the imaging device includes Doppler capabilities, the control unit can be configured to display Doppler information including flow rate, volume, pulse pressure, etc. In various embodiments, the control unit can display the treatment portion of the catheter in real time as the treatment portion advances through the patient's vasculature.

[0242]

[0328] As discussed herein, the method may include selecting a blood vessel for access. As described above, access to a vein or artery may be provided at the wrist or elsewhere. A catheter may be advanced through the blood vessel to a desired location, such as near a perforator. For example, referring to FIGS. 16A-16D , a view of a display 1240 showing axial cross-sectional image data from an imaging device 1206 is generally depicted. The imaging device 1206 may indicate that a catheter C is being advanced through an artery A, with accompanying veins V located on either side of the artery A. The catheter C may be advanced until a perforator P to one of the veins is visible on the display. The catheter C may continue to be advanced or retracted until the vein V from which the perforator extends indicates that the perforator has been introduced. This may be considered a desired location for vascular treatment (e.g., fistula creation) due to proximity to the origin of the perforator P.

[0243]

[0329] As described above, the control unit 1204 can be configured to determine the rotational position of the catheter, and more specifically, the treatment portion of the catheter. For example, as described above, the catheter C can include one or more position sensors (e.g., including information from an intravascular imaging device described herein) and / or echogenic markers, which can be recognized by the control unit 1204 (e.g., by image recognition processing) or can be communicatively coupled to the control unit 1204. The one or more position sensors and / or echogenic markers can enable the system to follow and / or track the orientation and / or position of the treatment portion (e.g., electrodes) of the catheter C and create an overlay, such as that shown in FIG. 16B , to guide a physician or other user. In particular, FIG. 16B shows an overlay displaying an indicator 1250 indicating the rotational position of the treatment portion of the catheter C. For example, an arrow 1252 indicates the position and cutting direction of the treatment portion, making the position and cutting direction of the treatment portion easily recognizable on the display 1240. Additionally, the overlay may depict a cutting depth indicator 1254 that may provide an indication of the overall cutting depth of the treatment portion of the catheter C. Figure 16B further illustrates rotation of the catheter to a desired orientation to guide it toward the treatment location within the vessel. During fistula formation, the treatment location may be the portion of the host vessel disposed closest to the target vessel.

[0244]

[0330] After the desired alignment is achieved, which the operator can determine from the display and the overlay projected on the display, the operator can deploy biasing mechanism D, as discussed above, to bias the treatment portion into contact with the treatment location on the blood vessel, as shown in Figure 16C. In Figure 16D, the operator can then administer the vascular treatment, which in the embodiment shown, results in the formation of a fistula 1260. Doppler and / or fluoroscopy can then be used to confirm the success of the treatment.

[0245]

[0331] It should be noted that while the examples provided above are directed to fistula formation using a single catheter, other treatments are contemplated and possible. Additionally, systems incorporating two catheters can be used as well. In such cases, each catheter can include an intravascular imaging device, and an overlay can provide rotational orientation of both catheters.

[0246]

[0332] However, as described herein, in various embodiments, the imaging device need not be an intravascular imaging device. In such embodiments, as described in more detail below, an actuator can be coupled to the imaging device and communicatively coupled to a control unit, such that the control unit can control the movement of the imaging device via the actuator. In such embodiments, the control unit can track the position of the treatment portion of the catheter via the imaging device, thereby showing real-time imaging of the treatment portion of the catheter on a display without requiring direct control of the imaging device by the operator.

[0247]

[0333] 17 schematically illustrates an alternative embodiment of a system 1300 for endovascular treatment of a blood vessel. Similar to system 1200 described above, system 1300 may include a communication path 1302, a control unit 1304, an imaging device 1306, and a display 1310. Unless otherwise described below, communication path 1302, control unit 1304, and display 1310 may be substantially identical to those described above in connection with system 1200. In addition, system 1300 may further include a user input device 1330, an actuator 1340, an electromagnetic field generator 1360, one or more position sensors 1380, and an energy source 1370. It should be noted that in various embodiments, fewer or more modules may be included in system 1300 without departing from the scope of the present disclosure. In addition, system 1300 includes one or more catheters, such as those described hereinabove. That is, system 1300 can include a single catheter system configured to create a fistula or deliver another type of vascular treatment to a target location within a vessel, or a two-catheter system configured to create a fistula or deliver some other type of vascular treatment between two catheters. Additionally, while various modules are described in connection with system 1300, it should be noted that such modules can also be incorporated into system 1200 described above without departing from the scope of the present disclosure.

[0248]

[0334] FIG. 18 generally illustrates portions of a system 1300 for endovascular treatment of blood vessels that can be provided within an examination room or clinic. As shown, various modules of the system can be mounted on a mobile cart 1390 that can be moved from room to room. Thus, the system 1300 can be moved to the user, improving the treatment location for the endovascular treatment. In other embodiments, a mobile cart may not be present. The mobile cart 1300 can support various components of the system, including, but not limited to, a control unit 1304, an imaging device 1306, a user input device 1304, an actuator 1340, etc.

[0249]

[0335] 18 , as described above, the system 1300 can include an imaging device 1306 communicatively coupled to the control unit 1304 via a communication path 1302. The imaging device 1306 can be an intravascular imaging device, as described above, or an external imaging device, as shown in FIG. 18 . The imaging device 1306 can be any device configured to provide images of a subject's blood vessels. For example, in at least one embodiment, the imaging device is an ultrasound imaging device. In some embodiments, the imaging device is a 2D or 3D ultrasound device capable of capturing images of the desired blood vessels along the frontal (coronal), axial (transverse / cross-sectional), and / or sagittal planes. The ultrasound device can be capable of performing various Doppler functions, including, but not limited to, color Doppler, power Doppler, and Doppler vector flow. Using the Doppler function, the system 1300 can analyze blood flow to determine arteries and veins. The system 1300 can indicate these different vessels, for example, using different color overlays on the display 1310, to allow the operator to quickly and efficiently determine which vessels are arteries and / or veins. Additionally, a Doppler function can be used to ensure the success of the treatment. For example, a Doppler function can make it possible to determine successful fistula creation. For example, Doppler can be used to identify or confirm blood flow through a fistula formed between two blood vessels. It should be noted that other imaging devices / solutions, including fluoroscopy, can also be used.

[0250]

[0336] 18 , the imaging device 1306 includes an ultrasound probe 1340. The ultrasound probe 1340 may be coupled to a movable cart 1390 via an actuator 1340 (e.g., a robotic arm 1342). In other embodiments, the ultrasound probe 1340 may not be coupled to a movable cart 1390.

[0251]

[0337] 17 and 18 together, in some embodiments, the imaging device 1306 can include a catheter tracking sensor 1380 coupled to the ultrasound probe 1320. The control unit 1304 can receive catheter tracking signals from the catheter tracking sensor 1380 and determine the location of the treatment portion of the catheter. As described in more detail herein, in some embodiments, the ultrasound probe 1320 can be coupled to an actuator 1340 configured to move the ultrasound probe 1380 along with the treatment portion of the catheter to track the location of the treatment portion of the catheter in real time (e.g., as the catheter advances through a blood vessel). In some embodiments, the control unit 1304 can be configured to perform image recognition on the ultrasound image to recognize the treatment portion of the catheter and determine the location of the treatment portion of the catheter relative to the imaging device 1306. For example, as described above, one or more catheters can include echogenic markers, and the control unit can be configured to recognize the echogenic markers via the imaging device 1306. Based on recognizing the echogenic markers, the control unit 1304 can control the movement of the imaging device 1406 via the actuator 134 to track the position of the treatment portion of the catheter in real time as the catheter advances through the blood vessel. Additionally, the control unit can adjust settings on the ultrasound probe 1320 to automatically focus on the treatment portion of the catheter and surrounding vascular structures and display a focused image on the display 1310. For example, based on the position of the echogenic markers, the control unit can automatically track the depth of the echogenic markers and adjust image quality settings.

[0252]

[0338] In some embodiments, the catheter tracking sensor 1380 can interact with a position sensor integrated into one or more catheters. For example, the catheter tracking sensor 1380 can detect a signal output by a position sensor integrated into the catheter to enable tracking of the position of the catheter treatment portion. In some embodiments, the system 1300 can include an electromagnetic field generator board 1360 that generates an electromagnetic field to facilitate tracking between the catheter tracking sensor 1340 and the catheter position sensor. Such an electromagnetic field generator board 1360 can be positioned, for example, below the user's treatment portion to generate an electromagnetic field around the user's treatment portion. With reference to FIG. 18 , the electromagnetic field generator board 1360 can be coupled to a subject support surface 1362. The control unit 1304 can be operable to control activation and deactivation of the electromagnetic field generator board 1360.

[0253]

[0339] As described herein, based on signals from the position sensor and / or tracking sensor 1340, the control unit 1304 can determine the position of the catheter's treatment portion and can be configured to automatically focus the imaging device settings to display various views of the catheter's treatment portion, including sagittal, axial, and / or coronal views. For example, based on signals from the position sensor, the control unit can automatically track the sensor's depth and adjust image quality settings. Such views can be centered around the catheter's treatment portion, with each view showing a cross-section of the catheter along a sagittal, axial, and / or coronal plane. FIG. 19A shows a display 1310 showing a catheter 200 with its treatment portion advanced through a vein V positioned adjacent to an artery A in coronal, axial, and sagittal planes. In some embodiments, the control unit 200 causes all three views to be displayed simultaneously. In other embodiments, the control unit 200 can display only two or fewer views. As described herein, the control unit 200 can be configured to recognize various portions of the vasculature and provide overlays that identify the vasculature. Such overlays may include labels, colors, etc. For example, the overlays may provide a blue overlay on arteries to indicate arterial flow and a blue overlay on veins to indicate venous flow. In some embodiments, the control unit may be configured to generate a three-dimensional model of the subject's vasculature. Referring to FIG. 19B , an exemplary three-dimensional model 1312 of a portion of the subject's vasculature is shown. For example, if an imaging device (e.g., a 2D or 3D ultrasound device) is used to track a catheter having position sensors and / or echogenic markers through an artery or vein, the control unit 200 may generate a three-dimensional model 1312 of the artery or vein A / V and display it on the display 1310. Surrounding veins and arteries may also be identified and generated as part of the three-dimensional map. The arteries and veins may be represented by different colors (e.g., red or blue) or otherwise labeled to allow the operator to distinguish between the two.

[0254]

[0340] 17 and 18 , the system 1300 may further include one or more user input devices 1330 communicatively coupled to the control unit 1304. The one or more user input devices 1330 may include any device capable of converting mechanical, optical, audible, or electrical signals into data signals that can be transmitted by the communication path 1302. Specifically, the user input device 1330 may include any number of movable objects that convert physical movements into data signals that can be transmitted over the communication path 1302, such as, for example, a joystick, a button, a keyboard, a switch, a knob, or a microphone. FIG. 18 illustrates the user input device 1330 mounted on a movable cart. Thus, the operator can input commands to the control unit 1304 via the user input device 1330. Such commands may include, but are not limited to, manual control of the imaging device to select a particular view or a particular overlay. Referring to FIG. 20 , an alternative user input device 1330 is generally depicted. Such a user input device 1330′ is shown as including a joystick 1332′. Based on user input from one or more user input devices 1330′, the control unit can be configured to switch from an auto-follow mode to a manual operating mode to allow manual control of the ultrasound probe 1380 based on input from the one or more user input devices 1330′.

[0255]

[0341] As described above, the system 1300 may further include an actuator 1340 communicatively coupled to the control unit 1304 and physically coupled to the imaging device 1306 (e.g., the ultrasound probe 1320). As described herein, the control unit 1304 may be configured to move the imaging device 1306 via the actuator 1340. FIG. 18 illustrates an embodiment in which the imaging device 1340 includes an ultrasound probe 1320 (e.g., a 3D ultrasound probe and / or a 2D ultrasound probe). The actuator 1340 may include a robotic arm 1342 coupled to the ultrasound probe 1340. The robotic arm 1342 may be capable of six degrees of freedom (or more) of movement to control the movement of the ultrasound probe 1320. The robotic arm 1342 may be coupled to a movable cart 1390 such that it is movable by the movable cart 1390.

[0256]

[0342] When using an external ultrasound imaging device, the ultrasound probe 1320 can include a subject-contacting surface 1322. The subject-contacting surface 1322 can be in contact with a subject's treatment area (e.g., arm, leg, torso, etc.) via a flexible subject interface / fluid barrier. That is, the subject-contacting surface 1322 can be in direct contact with the patient's treatment area (e.g., arm, leg, etc.) or can be in direct contact with a flexible fluid barrier 1408 that directly contacts the subject's treatment area. Such a fluid barrier can be provided as part of a media reservoir 1400 configured to be placed over the subject's treatment area. For example, the media reservoir 1400 as shown in FIG. 18 can include a fluid housing 1402 configured to hold fluid around the subject's treatment area. The fluid housing 1402 can include a shaped opening 1406 through which the subject's treatment area (e.g., arm, leg, etc.) can be placed. 21 shows a subject 1500 with an arm 1502 positioned within a molded opening 1406. A flexible fluid barrier 1408 (e.g., plastic) can be positioned between the subject 1500 and the fluid disposed within the fluid housing 1402 and can conform to the shape of the treatment area of ​​the subject 1500.

[0257]

[0343] After the subject 1500 is positioned, based on logic executed by the control unit 1304, the robotic arm 1342 can be manually or automatically controlled to position the ultrasound probe within the media bath 1400 and bring the subject contact surface 1322 into contact with the subject 1500. In various embodiments, the system 1300 can be used without a catheter to first map the subject's vasculature to locate a desired location for vascular treatment (e.g., fistula creation). As described herein, the system 1300 can be placed in an automatic catheter-following mode in which the control unit 1304 automatically controls the robotic arm 1342 so that the ultrasound probe 1306 follows the location of the treatment portion of the catheter as it is advanced through the subject's vasculature to the target treatment location.

[0258]

[0344] FIG. 22 illustrates an alternative embodiment of the system 1400 in which the actuator 1440 and imaging device 1306 are integrated into a fluid housing 1482 of a media vessel 1480. In such an embodiment, the fluid housing 1482 can include tracks 1484A / 1484B along which one or more ultrasound probes 1420A / 1420B (e.g., two probes) can follow back and forth. In such an embodiment, the actuator 1440 can include one or more linear actuators that interact with one or more ultrasound probes 1420A / 1420B to move the one or more ultrasound probes 1420A / 1420B along the tracks 1484A / 1484B. In some cases, such as in an embodiment in which two catheters are separately positioned within a subject's blood vessel, each probe can be separately controlled to track each catheter separately and provide image data for the treatment portion of each catheter.

[0259]

[0345] 23A and 23B show an alternative media vessel 1480' including a fluid housing 1482' and an ultrasonic probe 1420'. In the embodiment shown, the fluid housing 1482' defines a curved surface 1484' along which the curved ultrasonic probe 1420' travels. For example, a track 1486' can be coupled to the fluid housing 1482' at the apex of the curved surface 1484'. A linear actuator can be used to cause the curved ultrasonic probe to traverse the hardened surface 1484' of the fluid housing 1482'.

[0260]

[0346] 17 and 18 , the system 1300 can further include an energy source 1370 communicatively coupled to the control unit 1304. The energy source 1370 can be operably coupled to one or more catheters via electrical leads. The energy source 1370 can be an RF energy source for providing energy to electrodes in the treatment portions of the catheters, as described above. One or more user input devices 1330 can be used to input commands to the control unit 1304 to energize the electrodes for fistula formation. In some embodiments, the energy source 1370 can be mounted on a mobile cart 1390.

[0261]

[0347] As described above, in some embodiments, the systems provided herein can be used to scan an anatomical perspective region, construct 2D or 3D maps of veins and / or arteries, and display such maps on a display. For example, as described above, Doppler functionality can be used to enable the system to determine arterial and venous blood flow (e.g., Doppler functionality can measure flow direction, velocity, etc. to enable such determination). The control unit can execute logic to construct the 2D or 3D arterial map. In some embodiments, the generated 2D or 3D map can use different colors (e.g., red / blue) to indicate venous and / or arterial blood flow. Furthermore, as a catheter is advanced through the system, the catheter can be shown on the generated map as it advances through the vasculature. Such mapping can be integrated into a larger vascular map (e.g., a vascular map of an arm, leg, entire body, etc.) to enable a physician to review the subject's overall anatomy to determine appropriate treatment locations / areas. Doppler can be used to identify or confirm treatment success and indicate it on the 2D or 3D map. For example, if a fistula is created, the Doppler function can be used to identify new flow between adjacent vessels, determine that a fistula has been created, and adjust the 2D or 3D map to show the fistula.

[0262]

[0348] In some embodiments, not shown, during vascular treatment, a guidewire having an integrated tracking sensor proximate its tip can be inserted into the desired vein or artery and advanced to the target treatment location under the guidance of an imaging device. A catheter can then be advanced over the guidewire to the target treatment location using one or more position sensors or one or more echogenic markers or rings described herein, and the treatment portion of the catheter can be tracked and displayed in real time using a display device, with or without the use of fluoroscopy.

[0263]

[0349] As described herein, in various embodiments, an overlay can be placed over the image from the imaging device and displayed on the display to provide instructions regarding rotational alignment, longitudinal alignment, and distance (e.g., between the vessel and / or catheter). In addition, the overlay can also allow the user to determine whether the treatment portion is in contact with the treatment location within the vessel. For example, as described in more detail above, a biasing mechanism can be activated to bias the catheter to the correct location within the vessel for delivering the treatment (e.g., creating a fistula).

[0264]

[0350] 24A-24D illustrate the alignment of a two-catheter system, as described above. The catheters include a first catheter 101 advanced through a first blood vessel 1500 and a second catheter 103 advanced through a second blood vessel 1502. The first catheter 101 has a first treatment portion 110 (e.g., electrode 106) and one or more position sensors 121A / 121B positioned proximate the first treatment portion 110. The second catheter 103 has a second treatment portion 116 (e.g., recess 117) and one or more position sensors 123A / 123B positioned proximate the second treatment portion 116. A frontal view of the first and second catheters 101 / 103 within the blood vessels 1500 / 1502 is displayed on the display 1310. An indicator 1311 can be displayed on the display 1310 to indicate one or more alignment indicators. For example, the longitudinal alignment indicator indicates the longitudinal alignment of the first and second catheters 101 / 103, the proximity indicator indicates whether the first and second catheters 101 / 103 are sufficiently close to each other to deliver treatment (e.g., form a fistula), and the rotational indicator indicates whether the first and second treatment portions 110 / 116 are rotationally aligned with each other.

[0265]

[0351] When determining proximity, the control unit can track the position of each of the first and second treatment portions 110 / 116 based on signals from one or more position sensors 121A / 121B / 123A / 123B and / or one or more tracking sensors discussed above. Based on these signals, the control unit can determine whether the catheters are positioned within a predetermined distance range (e.g., less than 2 mm) where fistula formation will be located. FIG. 24B illustrates activation of the longitudinal indicator when the control unit determines that the first and second treatment portions 110 / 116 are longitudinally aligned with each other. FIG. 24C illustrates that the first and second catheters 101 / 103 have been moved into suitable proximity with each other so that a fistula can be formed. FIG. 24D illustrates that both the first catheter 101 and the second catheter 103 have proper rotational alignment so that a fistula can be formed. At this point, the electrode 106 of the treatment portion 110 of the first catheter 101 can be activated to ablate the tissue sandwiched between the first treatment portion 110 and the second treatment portion 116. The Doppler function of the imaging device can then be used to determine blood flow between the first blood vessel 1500 and the second blood vessel 1502 and confirm fistula formation.

[0266]

[0352] It should be noted that the external imaging devices described herein can be used to track and position the single catheter system as well.

[0353] As described herein, the devices and methods provided herein can be used for purposes other than fistula formation. For example, the devices provided herein can be used for vascular structure mapping, arterialization (e.g., arterialization of veins in cases of leg ischemia), vascular occlusion, angioplasty, thrombectomy, atherectomy, crossing, drug-coated balloon angioplasty, stent placement (uncovered and covered), lytic therapy, etc. In addition, the methods provided herein can include multiple treatments and / or multiple treatment sites.

[0267]

[0354] It should now be understood that the embodiments described herein are directed to systems, methods, and catheters for endovascular treatment of blood vessels. In particular, the embodiments described herein include an imaging device (e.g., an external or intravascular imaging device) that provides real-time imaging of the catheter, allowing the operator to quickly and efficiently determine the location and alignment of the treatment portion of the catheter. Furthermore, the embodiments described herein can enable the use of a single catheter for treatments such as fistula formation, thus simplifying such procedures for the operator and patient alike.

[0268]

[0355] It should be noted that the terms "substantially" and "about" may be used herein to express the inherent indeterminacy that may result from any quantitative comparison, value, measurement, or other expression. These terms are also used herein to express the extent to which a quantitative expression may vary from the stated basis without causing a change in the basic functionality of the subject matter in question.

[0269]

[0356] While particular embodiments have been illustrated and described herein, it should be understood that various other changes and modifications can be made without departing from the spirit and scope of the claimed subject matter. Moreover, although various aspects of the claimed subject matter have been described herein, such aspects need not be utilized in combination. It is therefore intended that the appended claims cover all such changes and modifications that fall within the scope of the claimed subject matter.

Claims

1. A catheter (101, 2000) for intravascular treatment of a blood vessel, comprising: a housing (113, 2008), a treatment portion (116, 2013), a fistula forming element (110, 2014), and an intravascular ultrasound imaging device (240, 2040); the intravascular ultrasound imaging device (240, 2040) further comprising a solid-state transducer array (2012); The catheter (101, 2000), wherein the intravascular ultrasound imaging device (240, 2040) further comprises one or more flexible circuit elements (2022) electrically coupled to the solid-state transducer array (2012).

2. the solid-state transducer array (2012) is disposed distal to the fistula forming element (110, 2014); or the solid-state transducer array (2012) is disposed proximal to the fistula forming element (110, 2014); or the solid-state transducer array (2012) is coupled to the housing (113, 2008) of the catheter (101, 2000); or the solid-state transducer array (2012) is circumferentially disposed around the housing (113, 2008) of the catheter (101, 2000); The catheter (101, 2000) of claim 1.

3. the one or more flexible circuit elements (2022) further comprise one or more multiplexed application integrated circuits; or the one or more flexible circuit elements (2022) are disposed within the housing (113, 2008) of the catheter (101, 2000); or the one or more flexible circuit elements (2022) are disposed distal to the stoma forming element (110, 2014) and proximal to the solid-state transducer array (2012); or the one or more flexible circuit elements (2022) are disposed proximate to the solid-state transducer array (2012), and the solid-state transducer array (2012) is disposed proximate to the stoma forming element (110, 2014); The catheter (101, 2000) of claim 1.

4. the one or more flexible circuit elements (2022) are disposed within the housing (113, 2008) of the catheter (101, 2000); The catheter (101, 2000) of claim 1, further comprising an intravascular ultrasound imaging device wire (2024) extending proximally from the one or more flexible circuit elements (2022) through the housing (113, 2008) of the catheter (101, 2000).

5. The catheter of claim 1 , wherein the fistula forming element (110, 2014) is an electrode configured to cauterize tissue.

6. The catheter (101, 2000) of claim 5, further comprising an electrode housing (2016), the electrode housing (2016) being positioned along the treatment portion (116, 2013) of the catheter (101, 2000), the electrode housing (2016) being at least partially positioned within the housing of the catheter (101, 2000).

7. When the electrode (106) is in a low profile configuration, the electrode (106) is contained within the electrode housing (2016); or the electrode (106) is configured to extend radially from the electrode housing (2016) and the housing (113, 2008) of the catheter (101, 2000) when the electrode (106) is in an extended configuration; or the electrode (106) is spring biased from a low profile configuration in which the electrode (106) is housed within the electrode housing (2016) to an extended configuration in which the electrode (106) extends radially from the electrode housing (2016) and the housing (113, 2008) of the catheter (101, 2000); A catheter (101, 2000) according to claim 6.

8. The catheter (101, 2000) of claim 6, wherein the intravascular ultrasound imaging device (240, 2040) further comprises a solid-state transducer array (2012), one or more flexible circuit elements (2022) electrically coupled to the solid-state transducer array (2012), and an intravascular ultrasound imaging device wire (2024) extending proximally from the one or more flexible circuit elements (2022) through the housing (113, 2008) of the catheter (101, 2000).

9. the electrode housing (2016) further comprises a channel (2026) extending therethrough, the solid-state transducer array (2012) being disposed distal to the electrode housing (2016), the one or more flexible circuit elements (2022) being disposed distal to the electrode housing (2016), and the intravascular ultrasound imaging device wire (2024) extending through the channel (2026) extending through the electrode housing (2016); or the catheter (101, 2000) further comprising a first lumen (2050) extending through the housing (113, 2008) of the catheter (101, 2000) and a second lumen (2060) extending through the housing (113, 2008) of the catheter (101, 2000); the electrode (106) further comprising an electrode wire (2020) electrically coupled to the electrode (106), the electrode wire extending proximally from the electrode (106) through the housing (113, 2008) of the catheter (101, 2000) within the first lumen (2050), and the intravascular ultrasound imaging device wire (2024) extending through the second lumen (2060); A catheter (101, 2000) according to claim 8.

10. a first lumen (2050) extending through the housing (113, 2008) of the catheter (101, 2000) and a second lumen (2060) extending through the housing (113, 2008) of the catheter (101, 2000), the electrode (106) further comprising an electrode wire (2020) electrically coupled to the electrode (106), the electrode wire extending proximally from the electrode (106) through the housing (113, 2008) of the catheter (101, 2000) within the first lumen (2050), the intravascular ultrasound imaging device wire (2024) extending through the second lumen (2060), The catheter of claim 8, wherein the first lumen further comprises an insulating sleeve.

11. The catheter (101, 2000) of claim 1, further comprising a biasing mechanism (220) coupled to the housing (113, 2008), the biasing mechanism (220) configured to contact a wall (1180, 1182) of the blood vessel and bias the treatment portion (116, 2013) into contact with the wall (1180, 1182) of the blood vessel.

12. the biasing mechanism (220) is configured to contact a first radial portion of the wall (1180, 1182) of the blood vessel and bias the treatment portion (116, 2013) toward a second radial portion of the wall (1180, 1182) of the blood vessel opposite the first radial portion; or the biasing mechanism (220) is a balloon; or the biasing mechanism (220) is an expandable cage; or the biasing mechanism (220) comprises one or more expandable wires (611) movable between a collapsed position and an expanded position, at least a portion of the one or more expandable wires (611) being positioned spaced apart from an outer wall of the housing (113, 2008) of the catheter (101, 2000); A catheter (101, 2000) according to claim 11.

13. the housing (113, 2008) further comprises a rapid exchange tip (2002) at the distal end of the catheter (101, 2000); or the housing (113, 2008) is comprised of one or more polymers, the housing (113, 2008) being preferably comprised of silicone rubber, nylon, polyurethane, polyethylene terephthalate, latex, or a thermoplastic elastomer, or the housing (113, 2008) being preferably further comprised of a braided polymer; A catheter (101, 2000) according to claim 10.